ChargePoint (CHPT) 10-K 1 Apr 24 2024 FY Annual report Financial data

Cover

Cover - USD ($) $ in Billions	12 Months Ended
	Jan. 31, 2024	Mar. 19, 2024	Jul. 31, 2023
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jan. 31, 2024
Current Fiscal Year End Date	--01-31
Document Transition Report	false
Entity File Number	001-39004
Entity Registrant Name	ChargePoint Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-1747686
Entity Address, Address Line One	240 East Hacienda Avenue
Entity Address, City or Town	Campbell
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95008
City Area Code	408
Local Phone Number	841-4500
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	CHPT
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Document Financial Statement Error Correction	false
Entity Public Float			$ 2.7
Entity Common Stock, Shares Outstanding		423,359,511
Documents Incorporated by Reference	Portions of the Registrant’s definitive proxy statement relating to its 2024 annual meeting of shareholders (the “2024 Proxy Statement”) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2024 Proxy Statement will be filed with the U.S. Securities Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Central Index Key	0001777393

Audit Information

Audit Information	12 Months Ended
	Jan. 31, 2024
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Firm ID	238
Auditor Location	San Jose, California

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 327,410	$ 264,162
Restricted cash	30,400	30,400
Short-term investments	0	104,966
Accounts receivable, net of allowance of $14,000 as of January 31, 2024 and $10,000 as of January 31, 2023	124,049	164,892
Inventories	198,580	68,730
Prepaid expenses and other current assets	62,244	71,020
Total current assets	742,683	704,170
Property and equipment, net	42,446	40,046
Intangible assets, net	80,555	92,673
Operating Lease, Right-of-Use Asset	15,362	22,242
Goodwill	213,750	213,716
Other assets	8,567	7,110
Total assets	1,103,363	1,079,957
Current liabilities:
Accounts payable	71,081	62,076
Accrued and other current liabilities	159,104	133,483
Deferred revenue	99,968	88,777
Total current liabilities	330,153	284,336
Deferred revenue, noncurrent	131,471	109,833
Debt, noncurrent	283,704	294,936
Operating lease liabilities	17,350	21,841
Deferred tax liabilities	11,252	12,987
Other long-term liabilities	1,757	1,032
Total liabilities	775,687	724,965
Commitments and contingencies
Temporary Equity [Abstract]
Redeemable convertible preferred stock: $0.0001 par value; zero and 0 shares authorized as of January 31, 2024 and 2023, respectively; zero and 0 shares issued and outstanding as of January 31, 2024 and 2023, respectively (liquidation value: nil and $0 as of January 31, 2024 and 2023, respectively)	0	0
Stockholders' equity:
Common stock: $0.0001 par value; 1,000,000,000 shares authorized as of each of January 31, 2024 and 2023; 421,116,720 and 348,330,481 shares issued and outstanding as of January 31, 2024 and 2023, respectively	42	35
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of each of January 31, 2024 and 2023; zero shares issued and outstanding as of each of January 31, 2024 and 2023	0	0
Additional paid-in capital	1,957,932	1,528,104
Accumulated other comprehensive loss	(15,926)	(16,384)
Accumulated deficit	(1,614,372)	(1,156,763)
Total stockholders' equity	327,676	354,992
Total liabilities and stockholders' equity	$ 1,103,363	$ 1,079,957
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Current assets:
Allowance for credit loss	$ 14,000	$ 10,000
Temporary Equity [Abstract]
Shares outstanding (in shares)	0	0
Stockholders' equity:
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common Stock, shares issued (in shares)	421,116,720	348,330,481
Common stock, shares outstanding (in shares)	421,116,720	348,330,481
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Restricted cash	$ 30,400	$ 30,400

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Revenue
Total revenue	$ 506,639,000	$ 468,094,000	$ 241,006,000
Cost of revenue
Total cost of revenue	476,521,000	382,161,000	187,473,000
Gross profit	30,118,000	85,933,000	53,533,000
Operating expenses
Research and development	220,781,000	194,957,000	145,043,000
Sales and marketing	150,186,000	142,392,000	92,550,000
General and administrative	109,102,000	90,366,000	81,380,000
Total operating expenses	480,069,000	427,715,000	318,973,000
Loss from operations	(449,951,000)	(341,782,000)	(265,440,000)
Interest income	9,603,000	5,534,000	98,000
Interest expense	(16,273,000)	(9,434,000)	(1,502,000)
Change in fair value of contingent earnout liability	0	0	84,420,000
Transaction costs expensed	0	0	(7,031,000)
Other expense, net	(1,009,000)	(1,569,000)	(2,775,000)
Net loss before income taxes	(457,630,000)	(347,275,000)	(135,171,000)
Benefit from income taxes	(21,000)	(2,167,000)	(2,930,000)
Net loss	(457,609,000)	(345,108,000)	(132,241,000)
Cumulative undeclared dividends on redeemable convertible preferred stock	0	0	(4,292,000)
Deemed dividends attributable to vested option holders	0	0	(51,855,000)
Deemed dividends attributable to common stock warrant holders	0	0	(110,635,000)
Net loss attributable to common stockholders - Basic	(457,609,000)	(345,108,000)	(299,023,000)
Gain attributable to earnout shares issued	0	0	(84,420,000)
Change in fair value of dilutive warrants	0	0	(68,223,000)
Net loss attributable to common stockholders - Diluted	$ (457,609,000)	$ (345,108,000)	$ (451,666,000)
Weighted average shares outstanding - Basic (in shares)	375,529,883	338,488,667	297,421,969
Weighted average shares outstanding - Diluted (in shares)	375,529,883	338,488,667	302,490,266
Net loss per share - Basic (USD per share)	$ (1.22)	$ (1.02)	$ (1.01)
Net loss per share - Diluted (USD per share)	$ (1.22)	$ (1.02)	$ (1.49)
Redeemable convertible preferred stock warrant
Operating expenses
Change in fair value of warrant liabilities	$ 0	$ 0	$ 9,237,000
Common stock warrant
Operating expenses
Change in fair value of warrant liabilities	0	(24,000)	47,822,000
Networked charging systems
Revenue
Total revenue	360,822,000	363,622,000	173,850,000
Cost of revenue
Total cost of revenue	386,149,000	318,628,000	147,313,000
Subscriptions
Revenue
Total revenue	120,445,000	85,296,000	53,512,000
Cost of revenue
Total cost of revenue	73,595,000	51,416,000	31,190,000
Other
Revenue
Total revenue	25,372,000	19,176,000	13,644,000
Cost of revenue
Total cost of revenue	$ 16,777,000	$ 12,117,000	$ 8,970,000

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (457,609)	$ (345,108)	$ (132,241)
Other comprehensive income (loss):
Foreign currency translation adjustment, net of tax	9	(7,716)	(8,374)
Available-for-sale short-term investments:
Unrealized loss on short-term investments, net of tax	0	(449)	0
Reclassification adjustment for net realized gains on short-term investments included in net income, net of tax	449	0	0
Other comprehensive income (loss)	458	(8,165)	(8,374)
Comprehensive loss	$ (457,151)	$ (353,273)	$ (140,615)

Consolidated Statements of Rede

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	182,934,257
Temporary equity, beginning balance at Jan. 31, 2021	$ 615,697
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	(182,934,257)
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend	$ (615,697)
Temporary equity, ending balance (in shares) at Jan. 31, 2022	0
Temporary equity, ending balance at Jan. 31, 2022	$ 0
Beginning balance (in shares) at Jan. 31, 2021		22,961,032
Beginning balance at Jan. 31, 2021	(616,521)	$ 2	$ 62,736	$ 155	$ (679,414)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)		194,060,336
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend	615,697	$ 20	615,677
Issuance of common stock under stock plans, net of tax withholding (in shares)		8,620,607
Issuance of common stock under stock plans, net of tax withholdings	4,516		4,516
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization	66,606		66,606
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)		60,746,989
Issuance of common stock upon the reverse recapitalization, net of issuance costs	200,466	$ 6	200,460
Issuance of common stock upon exercise of warrants (in shares)		16,364,810
Issuance of common stock upon exercise of warrants	352,613	$ 1	352,612
Common stock of switchback (in shares)		5,695,176
Issuance of common stock pursuant to business combinations	102,058	$ 1	102,057
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)		26,313,253
Issuance of earnout shares upon triggering events, net of tax withholding	480,225	$ 3	480,222
Contingent earnout liability recognized upon the closing of the reverse recapitalization	(828,180)		(828,180)
Reclassification of remaining contingent earnout liability upon triggering event	242,640		242,640
Vesting of early exercised stock options	$ 178		178
Repurchase of early exercised common stock (in shares)	(1,588)
Stock-based compensation	$ 67,331		67,331
Net loss	(132,241)				(132,241)
Other comprehensive income (loss)	(8,374)			(8,374)
Ending balance (in shares) at Jan. 31, 2022		334,760,615
Ending balance at Jan. 31, 2022	$ 547,014	$ 33	1,366,855	(8,219)	(811,655)
Temporary equity, ending balance (in shares) at Jan. 31, 2023	0
Temporary equity, ending balance at Jan. 31, 2023	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)		7,267,807
Issuance of common stock under stock plans, net of tax withholdings	2,502	$ 1	2,501
Issuance of common stock upon exercise of warrants (in shares)		1,041,533
Issuance of common stock upon exercise of warrants	6,932		6,932
Issuance of common stock upon ESPP purchase (in shares)		607,384
Issuance of common stock upon ESPP purchase	8,947		8,947
Issuance of common stock in connection with ATM offerings, net of issuance costs (in shares)		4,657,806
Issuance of common stock in connection with ATM offerings, net of issuance costs	49,450	$ 1	49,449
Vesting of early exercised stock options	$ 69		69
Repurchase of early exercised common stock (in shares)	(4,664)
Stock-based compensation	$ 93,351		93,351
Net loss	(345,108)				(345,108)
Other comprehensive income (loss)	(8,165)			(8,165)
Ending balance (in shares) at Jan. 31, 2023		348,330,481
Ending balance at Jan. 31, 2023	$ 354,992	$ 35	1,528,104	(16,384)	(1,156,763)
Temporary equity, ending balance (in shares) at Jan. 31, 2024	0
Temporary equity, ending balance at Jan. 31, 2024	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)		12,223,116
Issuance of common stock under stock plans, net of tax withholdings	3,763		3,763
Issuance of common stock upon ESPP purchase (in shares)		1,265,309
Issuance of common stock upon ESPP purchase	8,290		8,290
Issuance of common stock in connection with ATM offerings, net of issuance costs (in shares)		59,299,481
Issuance of common stock in connection with ATM offerings, net of issuance costs	287,199	$ 7	287,192
Vesting of early exercised stock options	$ 31		31
Repurchase of early exercised common stock (in shares)	(1,667)
Impact of convertible note modification	$ 13,225		13,225
Stock-based compensation	117,327		117,327
Net loss	(457,609)				(457,609)
Other comprehensive income (loss)	458			458
Ending balance (in shares) at Jan. 31, 2024		421,116,720
Ending balance at Jan. 31, 2024	$ 327,676	$ 42	$ 1,957,932	$ (15,926)	$ (1,614,372)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Cash flows from operating activities
Net loss	$ (457,609)	$ (345,108)	$ (132,241)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	28,486	25,050	16,457
Non-cash operating lease cost	4,343	4,739	4,244
Stock-based compensation	117,327	93,350	67,331
Amortization of deferred contract acquisition costs	2,859	2,361	1,786
Transaction costs expensed	0	0	7,031
Change in fair value of contingent earnout liability	0	0	(84,420)
Inventory impairment	70,000	0	0
Reserves and other	8,439	16,832	374
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	36,510	(94,600)	(38,388)
Inventories	(173,661)	(39,358)	(1,991)
Prepaid expenses and other assets	7,002	(37,969)	(23,941)
Accounts payable, operating lease liabilities, and accrued and other liabilities	(5,466)	55,827	26,092
Deferred revenue	32,829	51,803	55,281
Net cash used in operating activities	(328,941)	(267,049)	(157,178)
Cash flows from investing activities
Purchases of property and equipment	(19,424)	(18,563)	(16,410)
Purchases of investments	0	(284,835)	0
Maturities of investments	105,000	180,000	0
Cash paid for acquisition, net of cash acquired	0	(2,756)	(205,330)
Net cash provided by (used in) investing activities	85,576	(126,154)	(221,740)
Cash flows from financing activities
Proceeds from the exercise of public warrants	0	6,884	118,864
Merger and PIPE financing	0	0	511,646
Payment of tax withholding obligations on settlement of earnout shares	0	0	(20,895)
Repayment of borrowings	0	0	(36,051)
Proceeds from issuance of debt, net of issuance costs	0	293,972	0
Payments of transaction costs related to Merger	0	0	(32,468)
Change in driver funds and amounts due to customers	13,691	11,107	3,675
Debt issuance costs related to the revolving credit facility	(2,882)	0	0
Settlement of contingent earnout liability	(3,537)	0	0
Proceeds from issuance of stock in connection with stock plans, net of withholding taxes	12,054	11,446	4,916
Proceeds from issuance of common stock in connection with ATM offerings, net of issuance costs	287,198	49,450	0
Net cash provided by financing activities	306,524	372,859	549,687
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	89	(729)	(1,025)
Net increase (decrease) in cash, cash equivalents, and restricted cash	63,248	(21,073)	169,744
Cash, cash equivalents, and restricted cash at beginning of period	294,562	315,635	145,891
Cash, cash equivalents, and restricted cash at end of period	357,810	294,562	315,635
Supplementary cash flow information
Cash paid for interest	10,763	4,929	346
Cash paid for taxes	1,107	598	268
Supplementary cash flow information on non-cash investing and financing activities
Impact of convertible note modification	13,225	0	0
Right-of-use assets obtained in exchange for lease liabilities	536	0	7,991
Impairment charges and accelerated depreciation of right-of-use assets due to reorganization	5,647	0	0
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	2,095	1,954	660
Vesting of early exercised stock options	30	69	178
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization	0	0	615,697
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization	0	0	66,606
Contingent earnout liability recognized upon the closing of the reverse recapitalization	0	0	828,180
Reclassification of remaining contingent earnout liability upon triggering event	0	0	242,640
Issuance of common stock in connection with acquisitions	0	0	102,057
ViriCiti
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of contingent earnout liability	0	0	2,266
Common stock warrant
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	0	24	(47,822)
Redeemable convertible preferred stock warrant
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ 0	$ 0	$ (9,237)

Description of Business and Bas

Description of Business and Basis of Presentation	12 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation ChargePoint Holdings, Inc. (“ChargePoint” or the “Company”, “it”, or “its”) designs, develops and markets networked electric vehicle (“EV”) charging system infrastructure (“Networked Charging Systems”), connected through cloud-based services (“Cloud” or “Cloud Services”) which (i) enable charging system owners, or hosts, to manage their Networked Charging Systems, and (ii) enable drivers to locate, reserve and authenticate Networked Charging Systems, and to transact EV charging sessions on those systems. ChargePoint’s Networked Charging Systems, subscriptions and other offerings provide an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and full control, support and management of the Networked Charging Systems. This network also provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. In addition, the Company offers a range of extended warranties (“Assure”), as well as its ChargePoint as a Service (“CPaaS”) program which bundles use of ChargePoint owned and operated systems with Cloud Services, Assure and other benefits into one subscription. The Company’s fiscal year ends on January 31. References to fiscal years 2024, 2023, and 2022 relate to the fiscal years ended January 31, 2024, January 31, 2023, and January 31, 2022, respectively. Basis of Presentation The consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing and marketing its Networked Charging Systems, subscriptions and other offerings, raising capital, and recruiting personnel. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of January 31, 2024, the Company had an accumulated deficit of $1,614.4 million. The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, convertible notes, exercise proceeds from options and warrants, borrowings under its loan facilities, customer payments, proceeds from sale of Common Stock under the ATM Facility, and proceeds from the Merger. In February 2021, the Company received cash proceeds of $484.1 million from the Merger. The Company had cash, cash equivalents and restricted cash of $357.8 million as of January 31, 2024. As of the date on which these consolidated financial statements were issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months following the issuance of the consolidated financial statements. The Company’s assessment of the period of time its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its acquisitions, infrastructure, and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its Networked Charging Systems and Cloud Services platform, and the overall market acceptance of EVs. The Company has and may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. If additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, the Company may need to reorganize its operations including through further reductions in its workforce and its business, operating results, and financial condition would be materially adversely affected. Reverse Recapitalization On February 26, 2021, Lightning Merger Sub Inc., a wholly-owned subsidiary of Switchback Energy Acquisition Corporation (“Switchback”), merged with ChargePoint, Inc. (“Legacy ChargePoint”), with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback (the “Merger”). As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger (the “Closing”), Legacy ChargePoint’s outstanding series of redeemable convertible preferred stock were converted to Legacy ChargePoint common stock, which then converted to the Company’s common stock (“Common Stock”). In connection with the Merger, the Company raised $511.6 million of proceeds including the contribution of $286.6 million of cash held in Switchback’s trust account from its initial public offering, net of redemptions of Switchback public stockholders of $0.3 million, and $225.0 million of cash in connection with the PIPE financing. The Company incurred $36.5 million of transaction costs, consisting of banking, legal, and other professional fees, of which $29.5 million was recorded as a reduction to additional paid-in capital of proceeds and the remaining $7.0 million was expensed in the consolidated statements of operations. The Merger is accounted for as a reverse capitalization in accordance with U.S. GAAP. Acquisitions On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti Group B.V. (“ViriCiti”) for $79.4 million in cash, as well as $7.1 million of additional earnout consideration contingent on meeting certain revenue targets as of January 31, 2023 (“ViriCiti Earnout”), which was paid in full on March 6, 2023. ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States. On October 6, 2021, the Company acquired all of the outstanding shares of has•to•be gmbh (“HTB”) for approximately $235.0 million, consisting of $132.9 million in cash and $102.1 million in the form of 5,695,176 shares of ChargePoint Common Stock valued at $17.92 per share on the acquisition date. Of the cash component, $2.8 million was paid on February 3, 2022 as part of a working capital adjustment, and of the shares, 885,692 shares, valued at $15.9 million, were held in escrow to cover indemnity claims the Company could have made within eighteen months from the closing date and which were released to former HTB stockholders in April 2023. HTB is an Austria-based e-mobility provider with a European charging software platform.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Use of Estimates The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for expected credit losses, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, valuation of acquired goodwill and intangible assets, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts across large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments have historically consisted of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of January 31, 2024 and 2023, one customer individually accounted for 10% or more of accounts receivable, net. For the year ended January 31, 2024, there were no customers that represented 10% or more of total revenue. For the year ended January 31, 2023, there was one customer that represented 10% or more of total revenue. For the year ended January 31, 2022 there were no customers that represented 10% or more of total revenue. The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s operating results. Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value. Restricted cash relates to cash deposits restricted under letters of credit issued in support of customer and contract manufacturer agreements. The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows: January 31, 2024 2023 2022 (in thousands) Cash and cash equivalents $ 327,410 $ 264,162 $ 315,235 Restricted cash 30,400 30,400 400 Total cash, cash equivalents, and restricted cash $ 357,810 $ 294,562 $ 315,635 Short-Term Investments The Company's portfolio of marketable debt securities have historically been comprised solely of U.S. government securities with maturities of more than three months, but less than one year. The Company classifies these as available-for-sale at purchase date and will reevaluate such designation at each period end date. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. These debt securities were classified as current assets in the consolidated balance sheet and recorded at fair value, with unrealized gains or losses included in accumulated other comprehensive income (loss) and as a component of the consolidated statements of comprehensive loss. Gains and losses are recognized when realized. Gains and losses are determined using the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the consolidated balance sheets with a corresponding charge in other income (expense), net in the consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive income (loss). All of the short-term investments in U.S. Treasury securities have matured and no short-term investments remain outstanding as of January 31, 2024. As of January 31, 2023, short-term investments consisted of the following: January 31, 2023 Amortized Cost (1) Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) U.S. Treasury Securities $ 105,415 $ — $ (449) $ 104,966 _______________ (1) Amortized cost and fair value amounts included interest receivable The U.S. treasury securities were marketable debt securities stated on the consolidated balance sheets at fair value based upon inputs other than quoted prices in active markets (Level 2 inputs). The Company recorded $0.4 million of unrealized losses as a component of other comprehensive loss for the year ended January 31, 2023, which was reclassified out of other comprehensive loss at the maturity of the marketable debt securities during the year ended January 31, 2024. The Company did not recognize any gains or losses for either of the years ended January 31, 2024 and 2023. Accounts Receivable, net Accounts receivable for products, services and in certain scenarios charging sessions are recorded at the invoiced amount and are non-interest bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses related to its existing accounts receivable and net realizable value to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances, including the length of time receivables are past due, macroeconomic conditions, significant one-time events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance. The change in the allowance for expected credit losses for the years ended January 31, 2024, 2023, and 2022 was as follows: Beginning Change in Provision Write-offs Ending (in thousands) Year ended January 31, 2024 Allowance for expected credit losses $ 10,000 $ 6,026 $ (2,026) $ 14,000 Year ended January 31, 2023 Allowance for expected credit losses $ 5,584 $ 6,353 $ (1,937) $ 10,000 Year ended January 31, 2022 Allowance for expected credit losses $ 2,000 $ 3,835 $ (251) $ 5,584 Inventories Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a first-in, first-out basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Property and Equipment, net Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows: Useful Lives Furniture and fixtures 3 to 5 years Computers and software 3 to 5 years Machinery and equipment 3 to 5 years Tooling 3 to 5 years Useful Lives Leasehold improvements Shorter of the estimated lease term or useful life Owned and operated systems 5 to 7 years Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations. CPaaS combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets. Internal-Use Software Development Costs The Company capitalizes qualifying internal-use software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized internal-use software development costs is included within cost of revenue for Networked Charging Systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized. As of January 31, 2024 and 2023, capitalized costs have not been material. Leases Lessee The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease right-of-use (“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability. The term of the Company’s leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. The Company’s lease contracts often include lease and non-lease components. The Company has elected the practical expedient offered by the standard to not separate the lease from non-lease components and accounts for them as a single lease component. The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. Similar to other long-lived assets discussed below, the Company measures recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows that the assets or the asset group are expected to generate. If the carrying value of the assets are not recoverable, the impairment recognized is measured as the amount by which the carrying value of the asset exceeds its fair value. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. The Company committed to a decision to exit and sublease or cease use of certain facilities to align with the Company’s anticipated operating needs and incurred impairment charges related to real estate operating right-of-use assets of $2.7 million during the year ended January 31, 2024. Refer to Note 14, Restructuring , in the notes to the consolidated financial statements for further information. Lessor The Company leases Networked Charging Systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets. Impairment of Long-Lived Assets The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell. With the exception of impairment charges related to real estate operating right-of-use assets discussed above, there was no other material impairments of long-lived assets for the years ended January 31, 2024, 2023, and 2022. Business Combinations The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date. Goodwill Goodwill represents the excess of the purchase price of an acquired business over the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment at least annually, in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. As of January 31, 2024 and 2023, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the fourth quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit. The carrying value of goodwill was $213.8 million as of January 31, 2024 and $213.7 million as of January 31, 2023, and no goodwill impairment has been recognized to date. Intangible Assets Intangible assets consist primarily of customer relationships and developed technology. Acquired intangible assets are initially recorded at the acquisition-date fair value and amortized on a straight line basis over their estimated useful lives ranging from six Fair Value of Financial Instruments Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: • (Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; • (Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and • (Level 3) — Inputs that are unobservable for the asset or liability. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented. The carrying values of the Company’s cash equivalents, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. Certain assets, including goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge is recognized. The categorization of the framework used to measure fair value of the assets is considered to be within the Level 3 valuation hierarchy due to the subjective nature of the unobservable inputs used. As of January 31, 2024, there were no assets or liabilities that were measured at fair value on a recurring basis. As of January 31, 2023, the Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: Fair Value Measured as of January 31, 2023 Level 1 Level 2 Level 3 Total ( in thousands) Assets Money market funds $ 133,979 $ — $ — $ 133,979 U.S. Treasury securities — 104,966 — 104,966 Total financial assets $ 133,979 $ 104,966 $ — $ 238,945 The money market funds were classified as cash and cash equivalents on the consolidated balance sheets and were within Level 1 of the fair value hierarchy. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of January 31, 2024 and 2023. Realized gains and losses, net of tax, were not material for any of the periods presented. Short-term investments, consisting of U.S. treasury securities, were classified as available-for-sale on purchase date and recorded at fair value on the consolidated balance sheets. No short-term investments have been outstanding since April 30, 2023. There have been no Level 3 financial instruments outstanding since January 31, 2023. Debt Modification The Company evaluates amendments to its debt instruments in accordance with ASC 470-50, Debt Modifications and Extinguishments . This evaluation includes (1) if applicable, the change in fair value of an embedded conversion option to that of the carrying value of the debt immediately prior to amendment and (2) the net present value of future cash flows of the amended debt to that of the original debt to determine, in each case, if a change greater than 10% occurred. In instances where the net present value of future cash flows or the fair value of an embedded conversion option, if any, changed more than 10%, the Company applies extinguishment accounting. In instances where the net present value of future cash flows and the fair value of an embedded conversion option, if any, changed less than 10%, the Company obtains the fair value of the embedded conversion option to determine if the change in fair value is an increase of more than 10% of the carrying value of the debt immediately prior to the amendment. Revenue Recognition ChargePoint accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customer s (“ASC 606”). The Company recognizes revenue using the following five-step model as prescribed by ASC 606: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as Networked Charging Systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its Networked Charging Systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract. The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee. When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach. The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days. Networked Charging Systems revenue Networked Charging Systems revenue includes revenue related to the deliveries of EV charging system infrastructure and fees received for transferring regulatory credits earned for participating in low carbon fuel programs in jurisdictions with such programs. The Company recognizes revenue from sales of Networked Charging Systems upon shipment to the customer, which is when the performance obligation has been satisfied. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Subscriptions revenue Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions are considered for accounting purposes to contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis. Lessor revenue relates to operating leases and historically has not been material. Other revenue Other revenue consists of charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments colle

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The following table summarizes the changes in carrying amounts of goodwill: (in thousands) Balance as of January 31, 2022 $ 218,484 Foreign exchange fluctuations (4,768) Balance as of January 31, 2023 $ 213,716 Foreign exchange fluctuations 34 Balance as of January 31, 2024 $ 213,750 There was no impairment recognized for the years ended January 31, 2024, 2023, and 2022. Intangible Assets The following table presents the details of intangible assets: January 31, 2024 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 90,755 $ (21,301) $ 69,454 10 Developed technology 18,358 (7,257) 11,101 6 $ 109,113 $ (28,558) $ 80,555 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. January 31, 2023 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 90,738 $ (12,223) $ 78,515 10 Developed technology 18,355 (4,197) 14,158 6 $ 109,093 $ (16,420) $ 92,673 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. Amortization expense for customer relationships and developed technology is shown as sales and marketing and cost of revenue, respectively, in the consolidated statements of operations. The acquired intangible assets and goodwill are subject to impairment review at least annually on December 31st. Based on the annual impairment analysis completed during the years ended January 31, 2024 and 2023, the Company determined that there was no impairment of intangible assets. Acquisition-related intangible assets included in the above table are finite-lived and are carried at cost less accumulated amortization. Intangible assets are being amortized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. The following table presents the amortization expense related to intangible assets: Year ended January 31, 2024 2023 2022 (in thousands) Amortization Expense $ 12,140 $ 11,646 $ 4,617 The following table presents the estimated aggregate amortization expense related to intangible assets: Years Ending January 31, (in thousands) 2025 $ 12,134 2026 12,134 2027 12,134 2028 10,996 2029 9,075 Thereafter 24,082 Total amortization expense $ 80,555

Balance Sheet Components

Balance Sheet Components	12 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Inventories Inventories consisted of the following: January 31, 2024 2023 (in thousands) Raw materials $ 5,322 $ 11,509 Finished goods 193,258 57,221 Total Inventories $ 198,580 $ 68,730 During the fiscal year ended January 31, 2024, the Company recorded an impairment charge of $70.0 million to write down the carrying value of inventory on hand and charges for losses on non-cancelable purchase commitments to reduce the carrying value of certain products to their estimated net realizable value, address supply overruns related to product transitions, and to better align inventory with current demand. The inventory impairment charge is included in the cost of revenue - networked charging systems in the consolidated statements of operations. Prepaid expense and other current assets Prepaid expense and other current assets consisted of the following: January 31, 2024 2023 (in thousands) Prepaid expense $ 43,389 $ 48,464 Other current assets 18,855 22,556 Total Prepaid Expense and Other Current Assets $ 62,244 $ 71,020 Property and Equipment, net Property and equipment, net consisted of the following: January 31, 2024 2023 (in thousands) Furniture and fixtures $ 1,718 $ 1,244 Computers and software 8,520 7,164 Machinery and equipment 35,954 25,144 Tooling 15,852 13,782 Leasehold improvements 9,828 9,357 Owned and operated systems 27,723 24,119 Construction in progress 2,310 2,790 101,905 83,600 Less: Accumulated depreciation (59,459) (43,554) Total Property and Equipment, Net $ 42,446 $ 40,046 The following table presents the depreciation expense related to fixed assets: Year ended January 31, 2024 2023 2022 (in thousands) Depreciation Expense $ 16,345 $ 13,404 $ 11,840 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following: January 31, 2024 2023 (in thousands) Accrued expenses $ 51,399 $ 46,105 Reserve for losses on non-cancellable purchase commitments 30,054 7,287 Refundable customer deposits 16,588 14,551 Payroll and related expenses 16,018 21,495 Taxes payable 14,294 14,232 Other current liabilities (1) 30,751 29,813 Total Accrued and Other Current Liabilities $ 159,104 $ 133,483 _______________ (1) Beginning July 31, 2022, ViriCiti Earnout liability was reclassified from long-term liabilities to current liabilities as the Company expected the liability to be payable within twelve months of July 31, 2022. The ViriCiti Earnout liability was subsequently paid in full on March 6, 2023.

Leases

Leases	12 Months Ended
	Jan. 31, 2024
Leases [Abstract]
Leases	Leases The Company leases its office facilities under non-cancellable operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. As of January 31, 2024, non-cancellable leases expire on various dates between fiscal years 2025 and 2030. Generally, the Company's non-cancellable leases include renewal options to extend the lease term from one As of January 31, 2024 and 2023, lease balances were as follows: January 31, 2024 2023 (in thousands) Operating leases Operating lease right-of-use assets $ 15,362 $ 22,242 Operating lease liabilities, current 4,485 3,753 Operating lease liabilities, noncurrent 17,350 21,841 Total operating lease liabilities $ 21,835 $ 25,594 The Company recognizes operating lease costs on a straight-line basis over the lease period. Lease expense for the years ended January 31, 2024, 2023, and 2022 was $6.0 million, $6.6 million, and $6.1 million, respectively. Operating lease costs for short-term leases and variable lease costs were not material during the years ended January 31, 2024, 2023 and 2022. In September 2023, and subsequently in January 2024, the Company implemented reorganizations which included restructuring charges related to a decision to exit and sublease or cease use of certain facilities to align with the Company’s plan to reduce its operating expense and increase efficiencies. Refer to Note 14, Restructuring , in the notes to the consolidated financial statements in this Annual Report for more information. Future payments of operating lease liabilities under the Company’s non-cancellable operating leases as of January 31, 2024 were as follows: (in thousands) Years Ending January 31, 2025 $ 6,495 2026 5,198 2027 4,703 2028 4,100 2029 3,921 Thereafter 2,301 Total undiscounted operating lease payments $ 26,718 Less: imputed interest (4,883) Total operating lease liabilities $ 21,835 Other supplemental information as of January 31, 2024 and 2023 was as follows: January 31, 2024 2023 Lease Term and Discount Rate Weighted-average remaining operating lease term (years) 4.9 5.7 Weighted-average operating lease discount rate 7.4 % 7.3 % Other supplemental cash flow information for the years ended January 31, 2024, 2023 and 2022 was as follows: Year ended January 31, 2024 2023 2022 (in thousands) Supplemental Cash Flow Information Cash paid for amounts in the measurement of operating lease liabilities $ 6,760 $ 6,927 $ 5,164

Debt

Debt	12 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt 2018 Loan In July 2018, the Company entered into a term loan facility with certain lenders (the “2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under previous loans. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan was secured by substantially all of the Company’s assets, contained customary affirmative and negative covenants, and required the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan had a five In March 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million. There was no interest expense incurred during the years ended January 31, 2024 and 2023, respectively. Total interest expense incurred was $1.5 million for the year ended January 31, 2022. 2028 Convertible Notes The following table presents the Company’s convertible debt outstanding: Year Ended January 31, 2024 2023 (in thousands) Gross Amount $ 300,000 $ 300,000 Debt discount and issuance costs (16,296) (5,064) Carrying amount $ 283,704 $ 294,936 Estimated fair value (Level 2 Inputs) $ 211,000 $ 233,000 The following table presents the Company’s interest expense related to convertible debt: Twelve Months Ended January 31, 2024 2023 (in thousands) Contractual interest expense $ 13,548 $ 8,429 Amortization of debt discount and issuance costs 1993 965 Total interest expense $ 15,541 $ 9,394 In April 2022, the Company completed a private placement of $300 million aggregate principal amount of unsecured Convertible Senior PIK Toggle Notes (formerly, the “2027 Convertible Notes”, hereafter the “Original Convertible Notes”), the terms of which were amended in October 2023, as described below (the “Notes Amendment”). Prior to the Notes Amendment, the maturity date of the Original Convertible Notes was April 1, 2027. The Original Convertible Notes were sold in a private placement in reliance on the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”) provided by Section 4(a)(2) of the Securities Act . The net proceeds from the sale of the Original Convertible Notes were approximately $294.0 million after deducting initial purchaser discounts and commissions and the Company’s offering expenses. The debt discount and issuance costs, net of accumulated amortization, are reported as a direct deduction from the face amount of the Original Convertible Notes. The Company expects to use the net proceeds for general corporate purposes. Prior to the Notes Amendment, the Original Convertible Notes bore interest at 3.50% per annum, to the extent paid in cash (“Cash Interest”) or 5.00% per annum, to the extent paid in kind through the issuance of additional Original Convertible Notes (“PIK Interest”). Interest is payable semi-annually in arrears on April 1st and October 1st of each year, beginning on October 1, 2022. The Company can elect to make any interest payment through Cash Interest, PIK Interest or any combination thereof. The Original Convertible Notes are convertible, based on the applicable conversion rate, into cash, shares of the Company’s Common Stock or a combination thereof, at the Company’s election. The initial conversion rate was 41.6119 shares per $1,000 principal amount of the Original Convertible Notes, subject to customary anti-dilution adjustment in certain circumstances, which represented an initial conversion price of approximately $24.03 per share. Under the terms of the Original Convertible Notes, prior to January 1, 2027, the Original Convertible Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, and will be convertible on or after January 1, 2027, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the Original Convertible Notes. Holders of the Original Convertible Notes may convert all or a portion of their Original Convertible Notes prior to the close of business on January 1, 2027, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ended on September 30, 2022, if the Company’s closing Common Stock price for at least 20 trading days out of the most recent 30 consecutive trading days of the preceding calendar quarter is greater than or equal to 130% of the current conversion price of the Original Convertible Notes on each applicable trading day; • during the five business day period after any ten consecutive trading days in which the trading price per $1,000 principal amount of Original Convertible Notes for each trading day of such ten consecutive trading day period is less than 98% of the product of the Company’s closing Common Stock price and the conversion rate of the Original Convertible Notes on each such trading day; • if the Company calls the Original Convertible Notes for redemption, at any time prior to the close of business on the second business day immediately preceding the redemption date; or • upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental change or a transaction resulting in the Company’s Common Stock converting into other securities or property or assets. The Original Convertible Notes will be redeemable, in whole or in part, at the Company’s option at any time on or after April 21, 2025, and before the 41st scheduled trading day immediately before the maturity date. The redemption price will be equal to the aggregate principal amount of the Original Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, a holder may elect to convert its Original Convertible Notes during any such redemption period, in which case the applicable conversion rate may be increased in certain circumstances if the Original Convertible Notes are converted after they are called for redemption. Additionally, if the Company undergoes a fundamental change or a change in control transaction (each such term as defined in the indenture governing the Original Convertible Notes), subject to certain conditions, holders may require the Company to purchase for cash all or any portion of their Original Convertible Notes. The fundamental change repurchase price will be 100% of the capitalized principal amount of the Original Convertible Notes, while the change in control repurchase price will be 125% of the capitalized principal amount of the Original Convertible Notes to be purchased, in each case plus any accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the Original Convertible Notes includes a restrictive covenant that, subject to specified exceptions, limits the ability of the Company and its subsidiaries to incur secured debt in excess of $750.0 million. In addition, the indenture governing the Original Convertible Notes contains customary terms and covenants, including certain events of default in which case either the trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Original Convertible Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the Original Convertible Notes to be due and payable immediately. On October 24, 2023, the Original Convertible Notes were amended to (1) extend the maturity date from April 1, 2027 to April 1, 2028, (2) increase the Cash Interest rate to 7.0% from 3.5% and PIK Interest rate to 8.5% from 5.0%, (3) increase the initial conversion rate to 83.333 shares per $1,000 principal amount of the convertible notes from 41.6119 shares per $1,000 principal amount of the convertible notes, which represented a revised initial conversion price of approximately $12.00 per share, and (4) revise the make-whole table to reflect the revised terms of the convertible notes (herein, “2028 Convertible Notes”). Other than those previously stated, the terms of the 2028 Convertible Notes are not substantially different from the terms of Original Convertible Notes. The Company assessed the Notes Amendment for a debt extinguishment or modification in accordance with ASC 470-50, Debt Modifications and Extinguishments . As both the change in net present value of future cash flows of the 2028 Convertible Notes to that of the Original Convertible Notes and the change in fair value of the embedded conversion option of the 2028 Convertible Notes to that of the carrying value of the Original Convertible Notes immediately before modification resulted in a less than 10% change, the amendment is regarded as a modification. The resulting increase in fair value of the embedded conversion option is recorded as an increase in debt discount, a contra-liability account, as well as the corresponding entry to additional paid-in-capital, in the consolidated balance sheets. Legal fees and other costs incurred with third parties that were directly related to the debt modification were expensed as incurred. As of January 31, 2024, the new effective interest rate on the 2028 Convertible Notes was approximately 8.59%. Amortization of debt discount and issuance costs is reported as a component of interest expenses and is computed using the straight-line method over the term of the 2028 Convertible Notes, which approximates the effective interest method. The estimated fair value of the 2028 Convertible Notes, as of January 31, 2024 and 2023 using Level 2 fair value inputs, was $211.0 million and $233.0 million, respectively. 2027 Revolving Credit Facility On July 27, 2023, the Company entered into a revolving credit agreement by and among the Company, ChargePoint, Inc. (the “Borrower”), certain subsidiaries of the Borrower as guarantors (the “Subsidiary Guarantors”), JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto (the “Credit Agreement”). The Credit Agreement provides for senior secured revolving credit facility in an initial aggregate principal amount of up to $150.0 million, with a maturity date of January 1, 2027 (the “2027 Revolving Credit Facility”). Pursuant to the Credit Agreement, the Borrower may from time to time arrange for one or more increases in the commitments under the 2027 Revolving Credit Facility in an aggregate principal amount not to exceed $150.0 million, subject to obtaining the consent of the lenders participating in any such increase. Up to $100.0 million of the 2027 Revolving Credit Facility may be used for the issuance of letters of credit. The obligations of the Borrower under the Credit Agreement are guaranteed by the Company and the Subsidiary Guarantors and secured by a first priority pledge of the equity securities of the Borrower and certain of its subsidiaries and first priority security interests in substantially all tangible and intangible personal property, including intellectual property, of the Company, the Borrower and each Subsidiary Guarantor, subject to customary exceptions and limitations. The Credit Agreement contains negative covenants that, among other things, restrict the ability of the Company, the Borrower and its subsidiaries, as applicable, to incur additional indebtedness, incur additional liens, make investments or acquisitions, make dividends, distributions, or other restricted payments, dispose of property, and enter into transactions with affiliates, in each case subject to certain dollar baskets and customary carveouts, as well as customary events of default. In addition, the Credit Agreement requires the Borrower to comply with a minimum total liquidity covenant to be not less than 150% of the aggregate amount of the lender’s commitment under the Credit Agreement (“Total Liquidity”) which requires the Borrower to maintain, at all times, Total Liquidity equal to the sum of cash and cash equivalents held by the Borrower and the other loan parties at controlled accounts with the initial lenders under the Credit Agreement plus the aggregate unused amount of the commitments then available to be drawn under the 2027 Revolving Credit Facility. Borrowings under the 2027 Revolving Credit Facility may be denominated in U.S. dollars, Euros, or Pound Sterling. At the Company’s option, borrowings may bear interest at a rate per annum equal to either (a) an alternate base rate (for borrowings in U.S. dollars) plus a rate per annum of 1.75%, (b) an adjusted SOFR term rate (for borrowings in U.S. dollars) plus a rate per annum of 2.75%, (c) an adjusted EURIBOR rate (for borrowings in Euros) plus a rate per annum of 2.75%, or (d) a daily simple “risk-free” rate (for borrowings in Pounds Sterling) plus a rate per annum of 2.75%. The Company will pay commitment fees on the average daily unused amount of the 2027 Revolving Credit Facility at a rate per annum of 0.40%. In addition, the Company will also pay participation fees on the average daily undrawn amount of outstanding letters of credit at a rate per annum of 2.25%. In October 2023, the Company entered into an amendment to the Credit Agreement to, among other things, permit the Company to complete the Notes Amendment (as described above). As of January 31, 2024, the Borrower had no borrowings outstanding under the 2027 Revolving Credit Facility. The Borrower also had no letters of credit outstanding under the Credit Agreement as of January 31, 2024, and as a result, had a borrowing capacity of up to $150.0 million. The following presents the Company’s interest expense related to the 2027 Revolving Credit Facility: Twelve Months Ended January 31, 2024 (in thousands) Amortization of debt issuance costs $ 417 Commitment fees 315 Total interest expense $ 732

Commitment and Contingencies

Commitment and Contingencies	12 Months Ended
	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments Open purchase commitments are for the purchase of goods and services related to, but not limited to, manufacturing, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the consolidated balance sheets as of January 31, 2024 and 2023 as the Company had not yet received the related goods or services. Legal Proceedings The Company may be involved from time to time in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the consolidated financial statements indicates it is probable a loss has been incurred as of the date of the consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Class Action Litigation A class action lawsuit (the “November 2023 Class Action”) alleging violations of federal securities laws was filed on November 29, 2023 in the U.S. District Court for the Northern District of California against the Company and certain of its former officers (the “Class Defendants”). The complaint purports to be brought on behalf of purchasers of the Company’s common stock between June 1, 2023 and November 16, 2023 and alleges that the Class Defendants made materially false and misleading statements regarding component costs and supply overruns for DC charging products which resulted in impairment charges and an adverse impact on profitability. A second class action lawsuit (together with the November 2023 Class Action, the “Class Actions”) asserting the same claims and premised on the same underlying allegations, which purports to be on behalf of purchasers of the Company’s stock between December 7, 2021 and November 16, 2023, was filed against the Class Defendants on January 22, 2024. The complaints seek unspecified monetary damages and other relief. Applications to serve as lead plaintiff and to consolidate these two actions are pending with the court. No response to the complaints is required at this time; a deadline will be set following the court’s ruling on the pending applications. Derivative Actions On January 5, 2024, a ChargePoint stockholder purporting to act on behalf of the Company filed an action in the U.S. District Court for the District of Delaware against ChargePoint’s Board of Directors and certain of its former officers (“Derivative Defendants”), alleging that the Derivative Defendants breached their fiduciary duties to ChargePoint in connection with the same alleged events and alleged materially false and misleading statements asserted in the Class Actions described above. Two additional substantively duplicative actions were filed in the U.S. District Court for the Northern District of California on January 8, 2024 and March 1, 2024. The complaints seek unspecified monetary damages and other relief. This action has been stayed. The Company intends to defend these lawsuits vigorously. At this time, the Company is unable to predict the outcome or estimate the amount of loss or range of losses that could potentially result from these lawsuits. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying consolidated balance sheets. Guarantees and Indemnifications The Company has service level commitments to certain of its customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits in the event that the Company fails to meet those levels. To date, the Company has not incurred any material costs as a result of such commitments. The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the consolidated financial statements. The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. Letters of Credit The Company had $30.4 million of secured letters of credit outstanding as of both January 31, 2024 and 2023, respectively. These primarily relate to support of contract manufacturer and customer agreements, and are fully collateralized by cash deposits which the Company recorded in restricted cash on its consolidated balance sheets based on the term of the remaining restriction.

Common Stock

Common Stock	12 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Common Stock	Common Stock As of each of January 31, 2024 and 2023, the Company was authorized to issue 1,000,000,000 shares of Common Stock, with a par value of $0.0001 per share. There were 421,116,720 and 348,330,481 shares issued and outstanding as of January 31, 2024 and 2023, respectively. The holders of Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. The holders of Common Stock are not entitled to cumulative voting rights with respect to the election of directors, and as a consequence, minority stockholders are not able to elect directors on the basis of their votes alone. Subject to preferences that may be applicable to any shares of redeemable convertible preferred stock currently outstanding or issued in the future, holders of Common Stock are entitled to receive ratably such dividends as may be declared by the Company’s board of directors out of funds legally available therefor. In the event of the Company’s liquidation, dissolution, or winding up, holders of the Company’s Common Stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding redeemable convertible preferred stock. Holders of Common Stock have no preemptive rights and no right to convert their Common Stock into any other securities. There are no redemption or sinking fund provisions applicable to the Common Stock. At-the-Market Offering On July 1, 2022, ChargePoint filed a registration statement on Form S-3 (File No. 333-265986) with the SEC (that was declared effective by the SEC on July 12, 2022), which permits the Company to offer up to $1.0 billion of Common Stock, preferred stock, debt securities, warrants and rights in one or more offerings and in any combination, including in units from time to time (the “Shelf Registration Statement”). As part of the Shelf Registration Statement, ChargePoint filed a prospectus supplement registering for sale from time to time up to $500.0 million of Common Stock pursuant to a sales agreement (the “ATM Facility”).

Stock Warrants

Stock Warrants	12 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Stock Warrants	Stock Warrants Common Stock Warrants Legacy ChargePoint had outstanding warrants to purchase shares of Legacy ChargePoint common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. Immediately following the Merger, there were 38,761,031 Legacy Warrants outstanding which are classified as equity. During the fiscal year ended January 31, 2024, no Legacy Warrants were exercised. During the fiscal year ended January 31, 2023, 1,039,153 Legacy Warrants were exercised resulting in the issuance of 1,037,808 shares of Common Stock and cash proceeds received of $6.9 million. As of January 31, 2024, there were 34,499,436 Legacy Warrants outstanding which are classified as equity. January 31, 2024 Outstanding Warrants Expiration Date Number of Warrants Exercise Price Common Stock 20,922,215 $ 6.03 7/31/2030 – 8/4/2030 Common Stock 13,577,221 $ 9.04 11/16/2028 – 2/13/2029 Total outstanding common stock warrants 34,499,436 Private Placement Warrants The Private Placement Warrants were initially recognized as a liability on February 26, 2021 and was remeasured to fair value as of any respective exercise dates. The Company recorded no gain or loss, an immaterial loss, and a gain of $63.7 million for the fiscal years ended January 31, 2024, 2023 and 2022, respectively, classified within change in fair value of warrant liabilities in the consolidated statements of operations. The Private Placement Warrants were valued using the assumptions under the Binomial Lattice Model that assumes optimal exercise of the Company’s redemption option at the earliest possible date. On February 21, 2022, the Company redeemed the remaining Private Placement Warrants for 0.355 shares of Common Stock per warrant. As of January 31, 2024, there were zero Private Placement Warrants outstanding. January 31, February 26, 2021 (Merger Date) Market price of public stock $ 13.85 $ 30.83 Exercise price $ 11.50 $ 11.50 Expected term (years) 4.1 5.0 Volatility 70.5 % 73.5 % Risk-free interest rate 1.0 % 0.8 % Dividend rate 0.0 % 0.0 % Public Warrants The Public Warrants were initially recognized as a liability on February 26, 2021 and remeasured to fair value based upon the market price as warrants were exercised. On June 4, 2021 the Company issued a redemption notice pursuant to which all but 244,481 Public Warrants were exercised by the Public Warrant holders. At the conclusion of the redemption notice period on July 6, 2021, the Company redeemed the remaining 244,481 Public Warrants outstanding for $0.01 per warrant. As of January 31, 2024, no Public Warrants remained outstanding. The Company recognized no gain or loss for the fiscal years ended January 31, 2024 and 2023, and a loss of $15.9 million for the fiscal year ended January 31, 2022, classified within change in fair value of warrant liabilities Warrant Activity Activity of warrants is set forth below: Legacy Warrants Private Placement Warrants Total Common Stock Warrants Outstanding as of January 31, 2023 34,499,436 — 34,499,436 Warrants Exercised — — — Outstanding as of January 31, 2024 34,499,436 — 34,499,436

Equity Plans and Stock-based Co

Equity Plans and Stock-based Compensation	12 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Plans and Stock-Based Compensation	Equity Plans and Stock-Based Compensation The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s consolidated statements of operations: Year Ended January 31, 2024 2023 2022 (in thousands) Cost of revenue $ 6,154 $ 4,351 $ 3,782 Research and development 50,935 37,967 25,461 Sales and marketing 22,934 17,393 9,154 General and administrative 37,314 33,639 28,934 Total stock-based compensation expense $ 117,337 $ 93,350 $ 67,331 As of January 31, 2024, the Company had unrecognized stock-based compensation expense related to stock options, RSUs, PRSUs, and ESPP of $175.8 million, which is expected to be recognized over a weighted-average period of 2.6 years. 2021 Employee Stock Purchase Plan On February 25, 2021, the stockholders of the Company approved the 2021 Employee Stock Purchase Plan (“2021 ESPP”). The 2021 ESPP permits participants to purchase shares of the Company’s Common Stock, up to the IRS allowable limit, through contributions (in the form of payroll deductions or otherwise to the extent permitted by the administrator) of up to 15% of their eligible compensation. The 2021 ESPP provides for consecutive, overlapping 24-month offering periods, subject to certain rollover and reset mechanisms as defined in the ESPP. Participants are permitted to purchase shares of the Company’s Common Stock at the end of each 6-month purchase period at 85% of the lower of the fair market value of the Company’s Common Stock on the first trading day of an offering period or on the last trading date of each purchase period. A participant may purchase a maximum of 10,000 shares of the Company’s Common Stock during a purchase period. Participants may end their participation at any time during an offering and will be refunded any accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The initial offering period is from October 1, 2021 through September 9, 2023. Thereafter, offering periods will begin on March 10 and September 10. Further, on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of Common Stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of Common Stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares of Common Stock (subject to standard anti-dilution adjustments), or (iii) a number of shares of Common Stock determined by the Company’s Board of Directors. As of January 31, 2024, 13,139,772 shares of Common Stock were available under the 2021 ESPP. During the year ended January 31, 2024, the Company's employees purchased 1,273,933 shares of its Common Stock under the 2021 ESPP. The shares were purchased at a weighted-average purchase price of $6.54 per share, with proceeds of $8.3 million. During the year ended January 31, 2023, the Company’s employees purchased 607,384 shares of its Common Stock under the 2021 ESPP. The shares were purchased at a weighted-average purchase price of $14.73 per share, with proceeds of $8.9 million. 2021 Equity Incentive Plan On February 25, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (“2021 EIP”). Under the 2021 EIP, the Company can grant stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance restricted stock units (“PRSUs”), and certain other awards which are settled in the form of shares of Common Stock issued under this 2021 EIP. On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number equal to the lesser of (a) 5% of the total number of shares of Common Stock actually issued and outstanding on the last day of the preceding month and (b) a number of shares of Common Stock determined by the Company’s Board of Directors. As of January 31, 2024, 34,331,567 shares of Common Stock were available under the 2021 EIP. There were no options granted for the year ended January 31, 2024. Restricted Stock Units The 2021 EIP provides for the issuance of RSUs to employees and directors. A summary of activity of RSUs under the 2021 EIP at January 31, 2024 and changes during the periods then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 12,935,413 $ 15.02 RSU granted 26,348,986 $ 5.85 RSU vested (6,249,909) $ 13.53 RSU forfeited (4,618,363) $ 11.95 Outstanding as of January 31, 2024 28,416,127 $ 7.35 The total grant date fair value of RSUs vested during the year ended January 31, 2024, 2023 and 2022 were $84.5 million, $58.4 million, and $37.8 million, respectively. Performance Restricted Stock Units Pursuant to the 2021 EIP, the Company grants PRSUs to certain officers, including the Company’s Chief Executive Officer. Vesting of the PRSUs is dependent upon the satisfaction of both market- and service-based conditions occurring at the end of a four five- year A summary of activity of PRSUs under the 2021 EIP at January 31, 2024 and changes during the periods then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 2,147,366 $ 10.83 PRSU granted 1,621,236 $ 2.84 PRSU forfeited (620,820) $ 10.47 Outstanding as of January 31, 2024 3,147,782 $ 6.79 2017 Plan and 2007 Plan In fiscal year 2022, the Company terminated its 2017 Stock Option Plan (the “2017 Plan”) and 2007 Stock Option Plan (the “2007 Plan”). No further awards will be granted under the 2017 and 2007 Plans. As of January 31, 2024, 10,369,118 shares and 1,027,638 shares of Common Stock remain reserved for outstanding awards issued under the 2017 and 2007 Plans, respectively. Stock-based awards forfeited, cancelled or repurchased from the above plans generally are returned to the pool of shares of Common Stock available for issuance under the 2021 EIP Plan. Stock Options Activity A summary of option activity under the 2017 and 2007 Plans at January 31, 2024 and changes during the periods then ended is presented in the following table: Number of Weighted Weighted Aggregate Outstanding as of January 31, 2023 17,600,524 $ 0.70 5.6 $ 201,352 Exercised (5,976,138) $ 0.63 Cancelled (227,630) $ 0.77 Outstanding as of January 31, 2024 11,396,756 $ 0.74 4.8 $ 13,276 Options vested and expected to vest as of January 31, 2024 11,396,739 $ 0.74 4.8 $ 13,276 Exercisable as of January 31, 2024 11,301,564 $ 0.73 4.8 $ 13,167 The Company did not grant any options during the years ended January 31, 2024 and 2023. The total fair value of options vested during the years ended January 31, 2024, 2023, and 2022 was $46.3 million, $2.0 million, and $3.4 million, respectively. Determination of Fair Value The Company records stock-based compensation based on the grant date fair value of the equity instruments issued to employees and uses different appropriate methods to establish the fair value depending on the features of the awards. The grant date fair value of RSUs equals the fair market value of the Company’s Common Stock on the grant date. The Company utilizes the Black-Scholes option-pricing model to establish the fair value of stock options and ESPP, and the Monte Carlo simulation model to establish the fair value of PRSUs containing a market condition. The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of ESPP rights granted during the year ended January 31, 2024, 2023 and 2022 were as follows: Year Ended January 31, 2024 2023 2022 Expected volatility 62.3% - 70.8% 64.9% - 72.2% 61.8% - 73.5% Risk-free interest rate 4.5% - 5.4% 0.8% - 3.6% 0.1% - 0.3% Dividend rate 0.0 % 0.0 % 0.0 % Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.4 - 1.9 • Expected volatility: The expected volatility was determined by using a blended volatility approach of peer volatility and implied volatility. Peer volatility was calculated as the average of historical volatilities of selected industry peers deemed to be comparable to ChargePoint’s business corresponding to the expected term of the awards. • Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. • Expected dividend yield: The expected dividend rate is zero as ChargePoint currently has no history or expectation of declaring dividends on its Common Stock. • Expected term: The expected term represents the length of time the ESPP rights under each purchase period are outstanding. The weighted-average assumptions in the Monte Carlo valuation model used to determine the fair value of PRSUs granted during the year ended January 31, 2024 and 2023 were as follows: Year Ended January 31, 2024 2023 Expected volatility 68.4%- 82.4% 72.1% - 74.0% Risk-free interest rate 4.0% - 4.3% 2.8% - 3.3% Dividend rate 0.0 % 0.0 % Expected term (in years) 0.9 - 3.1 0.3 - 4.8 • Expected volatility: The expected volatility was determined using a blended volatility approach of historical volatility and implied volatility. • Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury Constant Maturities yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected term of the options. • Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends on its Common Stock. • Expected term: The expected term input for the award with a market condition is based upon the derived service period (“DSP”). The DSP represents the duration of the median of the distribution of stock-price paths on which the market condition is satisfied.

Income Taxes

Income Taxes	12 Months Ended
	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of net loss before income taxes were as follows: Year Ended January 31, 2024 2023 2022 (in thousands) Domestic $ (457,788) $ (342,999) $ (131,916) Foreign 158 (4,276) (3,255) Net loss before income taxes $ (457,630) $ (347,275) $ (135,171) The components of the provision for (benefit from) income taxes were as follows: Year Ended January 31, 2024 2023 2022 (in thousands) Current Federal $ 218 $ — $ — State 17 44 17 Foreign 1,942 1,345 359 Total current $ 2,177 $ 1,389 $ 376 Deferred Federal $ — $ 1 $ (1,242) State — — (423) Foreign (2,198) (3,557) (1,641) Total deferred (2,198) (3,556) (3,306) Total benefit from income taxes $ (21) $ (2,167) $ (2,930) A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows: Year Ended January 31, 2024 2023 2022 Tax at federal statutory rate 21.0 % 21.0 % 21.0 % State tax rate, net — % — % — % Warrant and earnout revaluation — % — % 20.9 % Stock-based compensation (2.6 %) — % 8.0 % Intangible assets amortization — % — % 1.3 % Change in valuation allowance (19.5 %) (18.9 %) (45.5 %) Transaction cost — % — % (1.2 %) Research and development tax credits 0.6 % 0.8 % 2.8 % Section 162(m) executive compensation limitation — % (1.2) % (5.3) % Other 0.6 % (1.1) % 0.2 % Effective tax rate 0.1 % 0.6 % 2.2 % The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2024 and 2023 were as follows: Year Ended January 31, 2024 2023 (in thousands) Deferred tax assets: Net operating losses $ 246,396 $ 216,642 Research & development credits 42,541 34,406 Deferred revenue 27,788 18,124 Accruals and reserves 47,279 18,837 Stock-based compensation 15,300 11,706 Operating lease liabilities 5,524 6,589 Capitalized research & development expense 69,070 39,761 Total deferred tax assets 453,898 346,065 Less: valuation allowance (439,447) (328,786) Deferred tax liabilities: Depreciation and amortization (557) (390) Operating lease right-of-use assets (3,886) (5,723) Acquired intangible assets (18,985) (22,058) Deferred commission (2,275) (2,095) Total deferred tax liabilities (25,703) (30,266) Net deferred tax assets (liabilities) $ (11,252) $ (12,987) Beginning January 1, 2022, the Tax Cuts and Jobs Act, or the Tax Act, eliminated the option to deduct research and development expenditures in the current year and requires taxpayers to capitalize such expenses pursuant to Internal Revenue Code Section 174. The capitalized expenses are amortized over a 5-year period for domestic expenses and a 15-year period for foreign expenses. The Company determines its valuation allowance on deferred tax assets by considering both positive and negative evidence in order to ascertain whether it is more likely than not that deferred tax assets will be realized. Realization of deferred tax assets is dependent upon the generation of future taxable income, if any, the timing and amount of which are uncertain. Due to the Company’s historical operating losses in the United States (“US”), the Company believes that it is more likely than not that the US deferred taxes will not be realized; accordingly, the Company has recorded a full valuation allowance on its net US deferred tax assets as of January 31, 2024 and 2023. The valuation allowance increased by $110.7 million, $88.2 million, and $89.6 million during the years ended January 31, 2024, 2023, and 2022, respectively, primarily driven by losses, capitalized research and development expenses, and tax credits generated in the United States. As of January 31, 2024, the Company had federal and California state net operating loss (“NOL”) carryforwards of $908.4 million and $408.1 million, respectively, of which $719.6 million of the federal NOL carryforwards can be carried forward indefinitely. The federal and California state net operating loss carryforwards begin to expire in 2028 and 2029, respectively. In addition, the Company had NOLs for other states of $375.7 million, which expire beginning in the year 2025. As of January 31, 2024, the Company had federal and California state research credit carryforwards of $41.1 million and $37.7 million, respectively. The federal credit carryforwards will begin to expire in 2038. The California research credit carryforwards can be carried forward indefinitely. Under Internal Revenue Code Section 382 (“Section 382”), the Company’s ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, an “ownership change.” A Section 382 ownership change generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. The Company completed its Section 382 analysis and determined it had experienced ownership changes in some periods through January 31, 2024. As a result of the ownership changes, approximately $17.1 million of Federal NOLs, $17.9 million of California NOLs, and $4.7 million of federal tax credits are expected to expire unutilized for income tax purposes. Subsequent ownership changes may affect the limitation in future years. The following table summarizes the activity related to unrecognized tax benefits as follows: Year Ended January 31, 2024 2023 2022 (in thousands) Unrecognized tax benefits - beginning $ 25,762 $ 19,238 $ 9,402 Gross changes - prior period tax position — 109 2,039 Gross changes - current period tax position 6,331 6,415 7,797 Unrecognized tax benefits — ending $ 32,093 $ 25,762 $ 19,238 As of January 31, 2024, the Company had unrecognized tax benefits of $32.1 million, which would not impact the effective tax rate, if recognized, due to the valuation allowance. The unrecognized tax benefits are related to activities which the Company believes qualify for research and development tax credits. The Company does not expect its unrecognized tax benefits will significantly change over the next twelve months. The Company recognizes interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties charged in relation to unrecognized tax benefits. The Company is subject to income taxes in United States federal and various state, local, and foreign jurisdictions. The fiscal years from 2008 to 2024 remain open to examination due to the carryover of unused net operating losses or tax credits. The Company intends to indefinitely reinvest the undistributed earnings of its foreign subsidiaries in those operations. Therefore, the Company has not accrued any provision for taxes associated with the repatriation of undistributed earnings from its foreign subsidiaries as of January 31, 2024. The amount of unrecognized deferred tax liability on these undistributed earnings was not material as of January 31, 2024.

Geographic Information

Geographic Information	12 Months Ended
	Jan. 31, 2024
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenue by geographic area based on the shipping address of the customers was as follows: Year Ended January 31, 2024 2023 2022 (in thousands) United States $ 380,067 $ 373,736 $ 205,186 Rest of World 126,572 94,358 35,820 Total revenue $ 506,639 $ 468,094 $ 241,006 Long-lived assets by geographic area were as follows: January 31, 2024 2023 (in thousands) United States $ 65,468 $ 71,032 Netherlands 66,241 76,747 Rest of World 6,654 7,182 Total long-lived assets $ 138,363 $ 154,961

Basic and Diluted Net Loss per

Basic and Diluted Net Loss per Share	12 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Basic and Diluted Net Loss per Share	Basic and Diluted Net Loss per Share The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2024, 2023, and 2022: Year Ended January 31, 2024 2023 2022 (in thousands, except share and per share data) Numerator: Net income (loss) $ (457,609) $ (345,108) $ (132,241) Adjust: Cumulative dividends on redeemable convertible preferred stock — — (4,292) Adjust: Deemed dividends attributable to vested option holders — — (51,855) Adjust: Deemed dividends attributable to common stock warrant holders — — (110,635) Net loss attributable to common stockholders - Basic $ (457,609) $ (345,108) $ (299,023) Less: Gain attributable to earnout shares issued — — (84,420) Less: Change in fair value of dilutive warrants — — (68,223) Net loss attributable to common stockholders - Diluted $ (457,609) $ (345,108) $ (451,666) Denominator: Weighted average common shares outstanding (1) 375,543,916 338,576,326 297,642,999 Less: Weighted-average unvested restricted shares and shares subject to repurchase (14,033) (87,659) (221,030) Weighted average shares outstanding - Basic 375,529,883 338,488,667 297,421,969 Add: Earnout Shares under the treasury stock method — — 3,701,427 Add: Public and Private Placement Warrants under the treasury stock method — — 1,366,870 Weighted average shares outstanding - Diluted 375,529,883 338,488,667 302,490,266 Net loss per share - Basic $ (1.22) $ (1.02) $ (1.01) Net loss per share - Diluted (2) $ (1.22) $ (1.02) $ (1.49) _______________ (1) For the fiscal year ended January 31, 2022, as a result of the Merger, the Company retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to the Closing Date by multiplying them by the Exchange Ratio of 0.9966 used to determine the number of shares of Common Stock into which they converted. The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis. (2) For the fiscal year ended January 31, 2022, redeemable convertible preferred stock and preferred stock warrants outstanding prior to the Merger Closing Date were excluded because including them would have had an antidilutive effect. The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows: Year Ended January 31, 2024 2023 2022 2028 Convertible Notes (on an as-converted basis) 24,999,990 12,483,569 — Options to purchase common stock 11,396,756 17,600,524 22,200,869 Restricted stock units 28,416,127 12,935,413 4,033,418 Unvested early exercised common stock options 665 40,555 132,180 Common stock warrants 34,499,436 34,499,436 35,549,024 Employee stock purchase plan 9,348,659 1,835,659 894,348 Total potentially dilutive common share equivalents 108,661,633 79,395,156 62,809,839

Restructuring

Restructuring	12 Months Ended
	Jan. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring January 2024 Reorganization In January 2024, the Company implemented a reorganization plan to reduce its operating expenses and further increase efficiencies (the “January 2024 Reorganization”). The January 2024 Reorganization entailed a reduction in force of approximately 223 employees, or 12% of the Company’s global workforce and other actions to reduce expenses. The Company incurred $9.9 million of employee severance, termination and employment-related exit costs and $2.7 million of facility exit costs, including impairment charges and accelerated depreciation of right-of-use assets. As of January 31, 2024, restructuring-related liabilities were $10.6 million, including $10.2 million in severance and employment-related exit cost and $0.4 million in facility exit cost. The following table summarizes the January 2024 Reorganization charges by line item within the Company’s consolidated statements of operations for the year ended January 31, 2024: Severances and employment-related termination costs Facility and other contract terminations Total (in thousands) Cost of revenue $ 632 $ — $ 632 Research and development 7,540 — 7,540 Sales and marketing 500 — 500 General and administrative 1,274 2,708 3,982 Total $ 9,946 $ 2,708 $ 12,654 September 2023 Reorganization In September 2023, the Company implemented a reorganization plan to reduce its operating expenses and increase efficiencies (the “September 2023 Reorganization”). The Reorganization entailed a reduction in force of approximately 168 employees, or 10% of the Company’s global workforce at the time, and other actions to reduce expenses. During the twelve months ended January 31, 2024, the Company incurred $15.6 million of employee severance, termination and employment-related exit cost, as well as accelerated depreciation of right-of-use assets and other facilities and contract termination charges. As of January 31, 2024, restructuring-related liabilities were $0.5 million, including $0.3 in severance and employment-related exit cost and $0.2 million in facility exit cost. The following table summarizes the September 2023 Reorganization charges by line item within the Company’s statement of operations for the year ended January 31, 2024: Severances and employment-related termination costs Facility and other contract terminations Total (in thousands) Cost of revenue $ 996 $ — $ 996 Research and development 4,183 — 4,183 Sales and marketing 1,343 — 1,343 General and administrative 890 8,189 9,079 Total $ 7,412 $ 8,189 $ 15,601

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (457,609)	$ (345,108)	$ (132,241)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jan. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for expected credit losses, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, valuation of acquired goodwill and intangible assets, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and Uncertainties	Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts across large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments have historically consisted of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Segment Reporting	Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company operates as one operating segment because its CODM, who is its Chief Executive Officer, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level.
Cash, Cash Equivalents, and Restricted Cash	The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value.
Short-term Investments	The Company's portfolio of marketable debt securities have historically been comprised solely of U.S. government securities with maturities of more than three months, but less than one year. The Company classifies these as available-for-sale at purchase date and will reevaluate such designation at each period end date. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. These debt securities were classified as current assets in the consolidated balance sheet and recorded at fair value, with unrealized gains or losses included in accumulated other comprehensive income (loss) and as a component of the consolidated statements of comprehensive loss. Gains and losses are recognized when realized. Gains and losses are determined using the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the consolidated balance sheets with a corresponding charge in other income (expense), net in the consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive income (loss).
Accounts Receivable, net	Accounts receivable for products, services and in certain scenarios charging sessions are recorded at the invoiced amount and are non-interest bearing. The Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses related to its existing accounts receivable and net realizable value to ensure trade receivables are not overstated due to uncollectibility. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results, or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables are further adjusted. The Company also considers broader factors in evaluating the sufficiency of its allowances, including the length of time receivables are past due, macroeconomic conditions, significant one-time events, and historical experience. When the Company determines that there are accounts receivable that are uncollectible, they are written off against the allowance.
Inventories	Inventories are stated at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost, on a first-in, first-out basis. Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. The Company analyzes current and future product demand relative to the remaining product life to identify potential excess inventories. The write-down is measured as the difference between the cost of the inventories and net realizable value and charged to inventory reserves, which is a component of cost of revenue. At the point of the loss recognition, a new, lower cost basis for those inventories is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Property and Equipment, net	Property and equipment are stated at cost, less accumulated depreciation and amortization. Leasehold improvements are amortized over the shorter of estimated useful lives of the assets or the lease term. Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in the consolidated statements of operations. CPaaS combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure into a single subscription. When CPaaS contracts contain a lease, the underlying asset is carried at its carrying value within property and equipment, net on the consolidated balance sheets.
Internal-Use Software Development Costs	The Company capitalizes qualifying internal-use software development costs incurred during the application development stage for internal tools and cloud-based applications used to deliver its services, provided that management with the relevant authority authorizes and commits to the funding of the project, it is probable the project will be completed, and the software will be used to perform the function intended. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized internal-use software development costs are included in property and equipment and are amortized on a straight-line basis over their estimated useful lives once it is ready for its intended use. Amortization of capitalized internal-use software development costs is included within cost of revenue for Networked Charging Systems and subscriptions, research and development expense, sales and marketing expense, and general and administrative expense based on the use of the software. Costs incurred for enhancements that are expected to result in additional material functionality are capitalized.
Leases, Lessee	Lessee The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease right-of-use (“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion, included within accrued and other current liabilities The Company’s lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability. The term of the Company’s leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also includes options to renew or extend the lease (including by not terminating the lease) that the Company is reasonably certain to exercise. The Company establishes the term of each lease at lease commencement and reassesses that term in subsequent periods when one of the triggering events outlined in ASC 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term. The Company’s lease contracts often include lease and non-lease components. The Company has elected the practical expedient offered by the standard to not separate the lease from non-lease components and accounts for them as a single lease component. The Company elected the package of practical expedients permitted under the transition guidance, which allows the Company to carry forward its historical lease classification, its assessment on whether a contract is or contains a lease, and its initial direct costs for any leases that existed prior to adoption of the new standard. The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. Similar to other long-lived assets discussed below, the Company measures recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows that the assets or the asset group are expected to generate. If the carrying value of the assets are not recoverable, the impairment recognized is measured as the amount by which the carrying value of the asset exceeds its fair value. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. The Company committed to a decision to exit and sublease or cease use of certain facilities to align with the Company’s anticipated operating needs and incurred impairment charges related to real estate operating right-of-use assets of $2.7 million during the year ended January 31, 2024. Refer to Note 14, Restructuring , in the notes to the consolidated financial statements for further information.
Leases, Lessor	The Company leases Networked Charging Systems to customers within certain CPaaS contracts. The leasing arrangements the Company enters into with lessees are operating leases, and as a result, the underlying asset is carried at its carrying value as owned and operated systems within property and equipment, net on the consolidated balance sheets.
Impairment of Long-Lived Assets	The Company evaluates long-lived assets or asset groups for impairment whenever events indicate that the carrying amount of an asset or asset group may not be recoverable based on expected future cash flows attributable to that asset or asset group. Recoverability of assets held and used is measured by comparison of the carrying amounts of an asset or an asset group to the estimated future undiscounted cash flows which the asset or asset group is expected to generate. If the carrying amount of an asset or asset group exceeds estimated undiscounted future cash flows, then an impairment charge would be recognized based on the excess of the carrying amount of the asset or asset group over its fair value. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell.
Business Combinations	The total purchase consideration for an acquisition is measured as the fair value of the assets transferred, equity instruments issued, and liabilities assumed at the acquisition date. Costs that are directly attributable to the acquisition are expensed as incurred and included in general and administrative expense in the Company’s consolidated statements of operations. Identifiable assets (including intangible assets), liabilities assumed (including contingent liabilities), and noncontrolling interests in an acquisition are measured initially at their fair values at the acquisition date. The Company recognizes goodwill if the fair value of the total purchase consideration and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, cost of capital, future cash flows, and discount rates. The Company’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. The Company includes the results of operations of the acquired business in the consolidated financial statements beginning on the acquisition date.
Goodwill	Goodwill represents the excess of the purchase price of an acquired business over the fair value of the net tangible and identifiable intangible assets acquired. The carrying amount of goodwill is reviewed for impairment at least annually, in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. As of January 31, 2024 and 2023, the Company had a single operating segment and reporting unit structure. As part of the annual goodwill impairment test performed in the fourth quarter, the Company first performs a qualitative assessment to determine whether further impairment testing is necessary. If, as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the quantitative impairment test will be required. If the Company has determined it necessary to perform a quantitative impairment assessment, the Company will compare the fair value of the reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill of the reporting unit.
Intangible Assets	Intangible assets consist primarily of customer relationships and developed technology. Acquired intangible assets are initially recorded at the acquisition-date fair value and amortized on a straight line basis over their estimated useful lives ranging from six
Fair Value of Financial Instruments	Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: • (Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; • (Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and • (Level 3) — Inputs that are unobservable for the asset or liability. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented. The carrying values of the Company’s cash equivalents, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. Certain assets, including goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge is recognized. The categorization of the framework used to measure fair value of the assets is considered to be within the Level 3 valuation hierarchy due to the subjective nature of the unobservable inputs used. The money market funds were classified as cash and cash equivalents on the consolidated balance sheets and were within Level 1 of the fair value hierarchy. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of January 31, 2024 and 2023. Realized gains and losses, net of tax, were not material for any of the periods presented. Short-term investments, consisting of U.S. treasury securities, were classified as available-for-sale on purchase date and recorded at fair value on the consolidated balance sheets. No short-term investments have been outstanding since April 30, 2023.
Debt Modification	Debt Modification The Company evaluates amendments to its debt instruments in accordance with ASC 470-50, Debt Modifications and Extinguishments . This evaluation includes (1) if applicable, the change in fair value of an embedded conversion option to that of the carrying value of the debt immediately prior to amendment and (2) the net present value of future cash flows of the amended debt to that of the original debt to determine, in each case, if a change greater than 10% occurred. In instances where the net present value of future cash flows or the fair value of an embedded conversion option, if any, changed more than 10%, the Company applies extinguishment accounting. In instances where the net present value of future cash flows and the fair value of an embedded conversion option, if any, changed less than 10%, the Company obtains the fair value of the embedded conversion option to determine if the change in fair value is an increase of more than 10% of the carrying value of the debt immediately prior to the amendment.
Revenue Recognition, Remaining Performance Obligations and Deferred Revenue	ChargePoint accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customer s (“ASC 606”). The Company recognizes revenue using the following five-step model as prescribed by ASC 606: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Significant judgment and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenue recognition. The Company enters into contracts with customers that regularly include promises to transfer multiple products and services, such as Networked Charging Systems, software subscriptions, extended maintenance, and professional services. For arrangements with multiple products or services, the Company evaluates whether the individual products or services qualify as distinct performance obligations. In its assessment of whether products or services are a distinct performance obligation, the Company determines whether the customer can benefit from the product or service on its own or with other readily available resources and whether the service is separately identifiable from other products or services in the contract. This evaluation requires the Company to assess the nature of each of its Networked Charging Systems, subscriptions, and other offerings and how each is provided in the context of the contract, including whether they are significantly integrated which may require judgment based on the facts and circumstances of the contract. The transaction price for each contract is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised products or services to the customer. Collectability of revenue is reasonably assured based on historical evidence of collectability of fees the Company charges its customers. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. Revenue is recorded based on the transaction price excluding amounts collected on behalf of third parties such as sales taxes, which are collected on behalf of and remitted to governmental authorities, or driver fees, collected on behalf of customers who offer public charging for a fee. When agreements involve multiple distinct performance obligations, the Company accounts for individual performance obligations separately if they are distinct. The Company applies significant judgment in identifying and accounting for each performance obligation, as a result of evaluating terms and conditions in contracts. The transaction price is allocated to the separate performance obligations on a relative standalone selling price (“SSP”) basis. The Company determines SSP based on observable standalone selling price when it is available, as well as other factors, including the price charged to its customers, its discounting practices, and its overall pricing objectives, while maximizing observable inputs. In situations where pricing is highly variable, or a product is never sold on a stand-alone basis, the Company estimates the SSP using the residual approach. The Company usually bills its customers at the onset of the arrangement for both the products and a predetermined period of time for services. Contracts for services typically range from annual to multi-year agreements with typical payment terms of 30 to 90 days. Networked Charging Systems revenue Networked Charging Systems revenue includes revenue related to the deliveries of EV charging system infrastructure and fees received for transferring regulatory credits earned for participating in low carbon fuel programs in jurisdictions with such programs. The Company recognizes revenue from sales of Networked Charging Systems upon shipment to the customer, which is when the performance obligation has been satisfied. Revenue from regulatory credits is recognized at the point in time the regulatory credits are transferred. Subscriptions revenue Subscriptions revenue consists of services related to Cloud, as well as extended maintenance service plans under Assure. Subscriptions revenue is recognized over time on a straight-line basis as the Company has a stand-ready obligation to deliver such services to the customer. Subscriptions revenue also consists of CPaaS revenue, which combines the customer’s use of the Company’s owned and operated systems with Cloud and Assure programs into a single subscription. CPaaS subscriptions are considered for accounting purposes to contain a lease for the customer’s use of the Company’s owned and operated systems unless the location allows the Company to receive incremental economic benefit from regulatory credits earned on that owned and operated system. The leasing arrangements the Company enters into with lessees are operating leases. The Company recognizes operating lease revenue on a straight-line basis over the lease term and expenses deferred initial direct costs on the same basis. Lessor revenue relates to operating leases and historically has not been material. Other revenue Other revenue consists of charging related fees received from drivers using charging sites owned and operated by the Company, net transaction fees earned for processing payments collected on driver charging sessions at charging sites owned by ChargePoint customers, and other professional services. Revenue from fees for owned and operated sites is recognized over time on a straight-line basis over the performance period of the service contract as the Company has a stand-ready obligation to deliver such services. Revenue from driver charging sessions and charging transaction fees is recognized at the point in time the charging session or transaction is completed. Revenue from professional services is recognized as the services are rendered.
Cost of Revenue	Cost of Networked Charging Systems revenue includes the material costs for parts and manufacturing costs for the hardware products, compensation, including salaries and related personnel expenses, including stock-based compensation, warranty provisions, depreciation of manufacturing related equipment and facilities, and allocated overhead costs. Costs for shipping and handling are recorded in cost of revenue as incurred. Cost of subscriptions revenue includes hosting, network and wireless connectivity costs for subscription services, field maintenance costs for Assure to support the Company’s network of systems, depreciation of owned and operated systems used in CPaaS arrangements, allocated overhead costs, and support costs to manage the systems and helpdesk services for site hosts. Cost of other revenue includes depreciation and other costs for ChargePoint’s owned and operated charging sites, charging related processing charges, salaries and related personnel expenses, including stock-based compensation, as well as costs of environmental and professional services. Costs to Obtain a Customer Contract Incremental and recoverable costs for the sale of cloud enabled software and extended maintenance service plans are capitalized as deferred contract acquisition costs within prepaid expenses and other current assets and other assets on the consolidated balance sheets and amortized on a straight-line basis over the anticipated benefit period of five years. The benefit period was estimated by taking into consideration the length of customer contracts, renewals, technology lifecycle, and other factors. This amortization is recorded within sales and marketing expense in the Company’s consolidated statements of operations. The sales commissions paid related to the sale of Networked Charging Systems are expensed as incurred. The Company elected the practical expedient that permits the Company to apply ASC Subtopic 340-40, “Other Assets and Deferred Costs--Contracts with Customers,” (“ASC 340”) to a portfolio containing multiple contracts, as they are similar in their characteristics, and the financial statement effects of applying ASC Subtopic 340-40 to that portfolio would not differ materially from applying it to the individual contracts within that portfolio.
Research and Development	Research and development expenses consist primarily of salary and related personnel expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s products and services, as well as quality assurance, testing, product management, and allocated overhead. Research and development costs are expensed as incurred.
Stock-based Compensation	The Company measures stock-based compensation expense for all stock-based awards granted to employees and directors based on the estimated fair value of the awards on the date of grant and recognizes stock-based compensation expense over the requisite service period. The Company estimates the fair value of stock options and rights granted under the employee stock purchase plan (“ESPP”) using the Black-Scholes option pricing model, and the Monte Carlo simulation model to estimate the fair value of performance restricted stock units (“PRSUs”). The fair value of restricted stock units (“RSUs”) equals the fair market value of the Company’s Common Stock on grant date. The Company amortizes the fair value of each stock award, except for market-based PRSU, on a straight-line basis over the requisite service period of the awards. For market-based PRSU, the Company amortizes using a graded-vesting attribution approach. Stock-based compensation expense is based on the value of the portion of stock-based awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
Advertising	The Company expenses the costs of advertising, including promotional expenses, as incurred.
Warranty	The Company provides standard warranty coverage on its products, providing parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost as a charge to Networked Charging Systems cost of revenue when revenue is recognized. The estimated warranty cost is based on historical and predicted product failure rates and repair expenses.
Warranty	In addition, the Company offers paid-for subscriptions to extended maintenance service plans under Assure. Assure provides both the labor and parts to maintain the products over the subscription terms of typically one
Foreign Currency	The functional currency of the Company’s foreign subsidiaries is generally the local currency. The translation of foreign currencies into U.S. dollars is performed for monetary assets and liabilities at the end of each reporting period based on the then current exchange rates. Non-monetary items are translated using historical exchange rates. For revenue and expense accounts, an average foreign currency rate during the period is applied. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as part of a separate component of stockholders’ equity (deficit) and reported in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net for the period.
Income Taxes	The Company uses the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax asset and liability. Valuation allowances are established when necessary to reduce deferred tax assets where it is more likely than not that the deferred tax assets will not be realized. In evaluating the Company’s ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including historical operating results, ongoing tax planning, and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Based on the level of historical losses, the Company has established a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based on the technical merits of the position.
Net Loss per Share Attributable to Common Stockholders	Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. The Company also considers any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have nonforfeitable dividend rights in the event a dividend is paid on common stock. Under the two-class method, net income is attributed to common stockholders and participating securities based on their participation rights. The holders of the redeemable convertible preferred stock, as well as the holders of early exercised shares subject to repurchase, do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended January 31, 2024, 2023, and 2022 were not allocated to these participating securities. Under the two-class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders adjusts basic net loss per share for the effect of dilutive securities, including stock options. Net loss amount is computed by adding deemed dividends and cumulative dividends on redeemable convertible preferred stock, to net loss. As such, the amount of the loss is increased by those instruments. When computing dilutive net loss, the numerator is also adjusted by changes in fair value attributable to dilutive warrants and gains attributable to Earnout Shares issued. As a result, some of the liability classified Company’s common stock warrants and Earnout Shares issued were dilutive, even though the Company reported losses for all periods presented.
Reclassifications of Prior Period Presentation	Reclassifications of Prior Period Presentation Certain prior period amounts have been reclassified for consistency with the current year presentation.
Accounting Pronouncements	Recently Adopted Accounting Standards In March 2022, the Financial Accounting Standards Board (“FASB”) issued ASU 2022-02, “ Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures,” which addresses areas identified by the FASB as part of its post-implementation review of ASU 2016-13, “ Financial Instruments--Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”) that introduced the current expected credit losses (“CECL”) model. The new guidance eliminates the accounting guidance for troubled debt restructurings by creditors that have already adopted the CECL model and enhances the disclosure requirements for loan refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the new guidance requires a public business entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination. The guidance is effective for public business entities that have adopted ASU 2016-13 for fiscal years beginning after December 31, 2022, including interim periods within those fiscal years. The Company adopted ASU 2022-02 on February 1, 2023 and elected to apply the amendments prospectively to all transactions within the scope of the amendment that are reflected in the financial statements at the date of adoption. The adoption did not have a material effect on the consolidated financial statements and related disclosures. Recent Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which amends and enhances the disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. All disclosure requirements under this standard will also be required for public entities with a single reportable segment. The guidance is effective for public business entities for the fiscal years beginning after December 15, 2023, including interim periods within fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of adopting this standard on the consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU No. 2023-09, “ Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires companies to provide disaggregated information about a reporting entity’s effective tax rate reconciliation as well as further disaggregation on income taxes paid disclosure by federal, state, and foreign taxes. The guidance is effective for public business entities for the fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of adopting this standard on the consolidated financial statements and related disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows: January 31, 2024 2023 2022 (in thousands) Cash and cash equivalents $ 327,410 $ 264,162 $ 315,235 Restricted cash 30,400 30,400 400 Total cash, cash equivalents, and restricted cash $ 357,810 $ 294,562 $ 315,635
Restrictions on Cash and Cash Equivalents	The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated statements of cash flows were as follows: January 31, 2024 2023 2022 (in thousands) Cash and cash equivalents $ 327,410 $ 264,162 $ 315,235 Restricted cash 30,400 30,400 400 Total cash, cash equivalents, and restricted cash $ 357,810 $ 294,562 $ 315,635
Investment	All of the short-term investments in U.S. Treasury securities have matured and no short-term investments remain outstanding as of January 31, 2024. As of January 31, 2023, short-term investments consisted of the following: January 31, 2023 Amortized Cost (1) Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) U.S. Treasury Securities $ 105,415 $ — $ (449) $ 104,966 _______________ (1) Amortized cost and fair value amounts included interest receivable
Accounts Receivable, Allowance for Credit Loss	The change in the allowance for expected credit losses for the years ended January 31, 2024, 2023, and 2022 was as follows: Beginning Change in Provision Write-offs Ending (in thousands) Year ended January 31, 2024 Allowance for expected credit losses $ 10,000 $ 6,026 $ (2,026) $ 14,000 Year ended January 31, 2023 Allowance for expected credit losses $ 5,584 $ 6,353 $ (1,937) $ 10,000 Year ended January 31, 2022 Allowance for expected credit losses $ 2,000 $ 3,835 $ (251) $ 5,584
Schedule of Property and Equipment, Net	Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows: Useful Lives Furniture and fixtures 3 to 5 years Computers and software 3 to 5 years Machinery and equipment 3 to 5 years Tooling 3 to 5 years Useful Lives Leasehold improvements Shorter of the estimated lease term or useful life Owned and operated systems 5 to 7 years Property and equipment, net consisted of the following: January 31, 2024 2023 (in thousands) Furniture and fixtures $ 1,718 $ 1,244 Computers and software 8,520 7,164 Machinery and equipment 35,954 25,144 Tooling 15,852 13,782 Leasehold improvements 9,828 9,357 Owned and operated systems 27,723 24,119 Construction in progress 2,310 2,790 101,905 83,600 Less: Accumulated depreciation (59,459) (43,554) Total Property and Equipment, Net $ 42,446 $ 40,046 The following table presents the depreciation expense related to fixed assets: Year ended January 31, 2024 2023 2022 (in thousands) Depreciation Expense $ 16,345 $ 13,404 $ 11,840
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	As of January 31, 2024, there were no assets or liabilities that were measured at fair value on a recurring basis. As of January 31, 2023, the Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: Fair Value Measured as of January 31, 2023 Level 1 Level 2 Level 3 Total ( in thousands) Assets Money market funds $ 133,979 $ — $ — $ 133,979 U.S. Treasury securities — 104,966 — 104,966 Total financial assets $ 133,979 $ 104,966 $ — $ 238,945
Schedule of Deferred Revenue	The following table shows the total deferred revenue for each period presented. January 31, 2024 January 31, 2023 (in thousands) Total deferred revenue $ 231,439 $ 198,610 The following table shows the revenue recognized that was included in the deferred revenue balance at the beginning of the period. Year Ended January 31, 2024 2023 2022 (in thousands) Total deferred revenue recognized $ 88,777 $ 77,142 $ 40,934
Deferred Policy Acquisition Costs	Changes in the deferred contract acquisition costs during the years ended January 31, 2024 and 2023 were as follows: (in thousands) Balance as of January 31, 2022 $ 7,129 Capitalization of deferred contract acquisition costs 3,374 Amortization of deferred contract acquisition costs (2,361) Balance as of January 31, 2023 $ 8,142 Capitalization of deferred contract acquisition costs 3,711 Amortization of deferred contract acquisition costs (2,859) Balance as of January 31, 2024 $ 8,994 Deferred acquisition costs capitalized on the consolidated balance sheets were as follows: January 31 2024 2023 (in thousands) Deferred contract acquisition costs, current $ 3,013 $ 2,598 Deferred contract acquisition costs, noncurrent 5,981 5,544 Total deferred contract acquisition costs $ 8,994 $ 8,142

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the changes in carrying amounts of goodwill: (in thousands) Balance as of January 31, 2022 $ 218,484 Foreign exchange fluctuations (4,768) Balance as of January 31, 2023 $ 213,716 Foreign exchange fluctuations 34 Balance as of January 31, 2024 $ 213,750 There was no impairment recognized for the years ended January 31, 2024, 2023, and 2022.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The following table presents the details of intangible assets: January 31, 2024 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 90,755 $ (21,301) $ 69,454 10 Developed technology 18,358 (7,257) 11,101 6 $ 109,113 $ (28,558) $ 80,555 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. January 31, 2023 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 90,738 $ (12,223) $ 78,515 10 Developed technology 18,355 (4,197) 14,158 6 $ 109,093 $ (16,420) $ 92,673 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates.
Schedule of Finite-Lived Intangible Assets Amortization Expense	The following table presents the amortization expense related to intangible assets: Year ended January 31, 2024 2023 2022 (in thousands) Amortization Expense $ 12,140 $ 11,646 $ 4,617
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The following table presents the estimated aggregate amortization expense related to intangible assets: Years Ending January 31, (in thousands) 2025 $ 12,134 2026 12,134 2027 12,134 2028 10,996 2029 9,075 Thereafter 24,082 Total amortization expense $ 80,555

Balance Sheet Components (Table

Balance Sheet Components (Tables)	12 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Inventories	Inventories consisted of the following: January 31, 2024 2023 (in thousands) Raw materials $ 5,322 $ 11,509 Finished goods 193,258 57,221 Total Inventories $ 198,580 $ 68,730
Schedule of Other Current Assets	Prepaid expense and other current assets consisted of the following: January 31, 2024 2023 (in thousands) Prepaid expense $ 43,389 $ 48,464 Other current assets 18,855 22,556 Total Prepaid Expense and Other Current Assets $ 62,244 $ 71,020
Schedule of Property and Equipment, Net	Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets, as follows: Useful Lives Furniture and fixtures 3 to 5 years Computers and software 3 to 5 years Machinery and equipment 3 to 5 years Tooling 3 to 5 years Useful Lives Leasehold improvements Shorter of the estimated lease term or useful life Owned and operated systems 5 to 7 years Property and equipment, net consisted of the following: January 31, 2024 2023 (in thousands) Furniture and fixtures $ 1,718 $ 1,244 Computers and software 8,520 7,164 Machinery and equipment 35,954 25,144 Tooling 15,852 13,782 Leasehold improvements 9,828 9,357 Owned and operated systems 27,723 24,119 Construction in progress 2,310 2,790 101,905 83,600 Less: Accumulated depreciation (59,459) (43,554) Total Property and Equipment, Net $ 42,446 $ 40,046 The following table presents the depreciation expense related to fixed assets: Year ended January 31, 2024 2023 2022 (in thousands) Depreciation Expense $ 16,345 $ 13,404 $ 11,840
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following: January 31, 2024 2023 (in thousands) Accrued expenses $ 51,399 $ 46,105 Reserve for losses on non-cancellable purchase commitments 30,054 7,287 Refundable customer deposits 16,588 14,551 Payroll and related expenses 16,018 21,495 Taxes payable 14,294 14,232 Other current liabilities (1) 30,751 29,813 Total Accrued and Other Current Liabilities $ 159,104 $ 133,483 _______________ (1) Beginning July 31, 2022, ViriCiti Earnout liability was reclassified from long-term liabilities to current liabilities as the Company expected the liability to be payable within twelve months of July 31, 2022. The ViriCiti Earnout liability was subsequently paid in full on March 6, 2023.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jan. 31, 2024
Leases [Abstract]
Assets and Liabilities, Lessee	As of January 31, 2024 and 2023, lease balances were as follows: January 31, 2024 2023 (in thousands) Operating leases Operating lease right-of-use assets $ 15,362 $ 22,242 Operating lease liabilities, current 4,485 3,753 Operating lease liabilities, noncurrent 17,350 21,841 Total operating lease liabilities $ 21,835 $ 25,594
Lessee, Operating Lease, Liability, Maturity	Future payments of operating lease liabilities under the Company’s non-cancellable operating leases as of January 31, 2024 were as follows: (in thousands) Years Ending January 31, 2025 $ 6,495 2026 5,198 2027 4,703 2028 4,100 2029 3,921 Thereafter 2,301 Total undiscounted operating lease payments $ 26,718 Less: imputed interest (4,883) Total operating lease liabilities $ 21,835
Lease, Cost	Other supplemental information as of January 31, 2024 and 2023 was as follows: January 31, 2024 2023 Lease Term and Discount Rate Weighted-average remaining operating lease term (years) 4.9 5.7 Weighted-average operating lease discount rate 7.4 % 7.3 % Other supplemental cash flow information for the years ended January 31, 2024, 2023 and 2022 was as follows: Year ended January 31, 2024 2023 2022 (in thousands) Supplemental Cash Flow Information Cash paid for amounts in the measurement of operating lease liabilities $ 6,760 $ 6,927 $ 5,164

Debt (Tables)

Debt (Tables)	12 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Convertible Debt	The following table presents the Company’s convertible debt outstanding: Year Ended January 31, 2024 2023 (in thousands) Gross Amount $ 300,000 $ 300,000 Debt discount and issuance costs (16,296) (5,064) Carrying amount $ 283,704 $ 294,936 Estimated fair value (Level 2 Inputs) $ 211,000 $ 233,000
Schedule of Interest Expense, Debt	The following table presents the Company’s interest expense related to convertible debt: Twelve Months Ended January 31, 2024 2023 (in thousands) Contractual interest expense $ 13,548 $ 8,429 Amortization of debt discount and issuance costs 1993 965 Total interest expense $ 15,541 $ 9,394 The following presents the Company’s interest expense related to the 2027 Revolving Credit Facility: Twelve Months Ended January 31, 2024 (in thousands) Amortization of debt issuance costs $ 417 Commitment fees 315 Total interest expense $ 732

Stock Warrants (Tables)

Stock Warrants (Tables)	12 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Schedule of Warrants	As of January 31, 2024, there were 34,499,436 Legacy Warrants outstanding which are classified as equity. January 31, 2024 Outstanding Warrants Expiration Date Number of Warrants Exercise Price Common Stock 20,922,215 $ 6.03 7/31/2030 – 8/4/2030 Common Stock 13,577,221 $ 9.04 11/16/2028 – 2/13/2029 Total outstanding common stock warrants 34,499,436 Activity of warrants is set forth below: Legacy Warrants Private Placement Warrants Total Common Stock Warrants Outstanding as of January 31, 2023 34,499,436 — 34,499,436 Warrants Exercised — — — Outstanding as of January 31, 2024 34,499,436 — 34,499,436
Fair Value Measurement Inputs and Valuation Techniques	The Private Placement Warrants were valued using the assumptions under the Binomial Lattice Model that assumes optimal exercise of the Company’s redemption option at the earliest possible date. On February 21, 2022, the Company redeemed the remaining Private Placement Warrants for 0.355 shares of Common Stock per warrant. As of January 31, 2024, there were zero Private Placement Warrants outstanding. January 31, February 26, 2021 (Merger Date) Market price of public stock $ 13.85 $ 30.83 Exercise price $ 11.50 $ 11.50 Expected term (years) 4.1 5.0 Volatility 70.5 % 73.5 % Risk-free interest rate 1.0 % 0.8 % Dividend rate 0.0 % 0.0 %

Equity Plans and Stock-based _2

Equity Plans and Stock-based Compensation (Tables)	12 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s consolidated statements of operations: Year Ended January 31, 2024 2023 2022 (in thousands) Cost of revenue $ 6,154 $ 4,351 $ 3,782 Research and development 50,935 37,967 25,461 Sales and marketing 22,934 17,393 9,154 General and administrative 37,314 33,639 28,934 Total stock-based compensation expense $ 117,337 $ 93,350 $ 67,331
Share-based Payment Arrangement, Option, Activity	A summary of option activity under the 2017 and 2007 Plans at January 31, 2024 and changes during the periods then ended is presented in the following table: Number of Weighted Weighted Aggregate Outstanding as of January 31, 2023 17,600,524 $ 0.70 5.6 $ 201,352 Exercised (5,976,138) $ 0.63 Cancelled (227,630) $ 0.77 Outstanding as of January 31, 2024 11,396,756 $ 0.74 4.8 $ 13,276 Options vested and expected to vest as of January 31, 2024 11,396,739 $ 0.74 4.8 $ 13,276 Exercisable as of January 31, 2024 11,301,564 $ 0.73 4.8 $ 13,167
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The weighted-average assumptions in the Monte Carlo valuation model used to determine the fair value of PRSUs granted during the year ended January 31, 2024 and 2023 were as follows: Year Ended January 31, 2024 2023 Expected volatility 68.4%- 82.4% 72.1% - 74.0% Risk-free interest rate 4.0% - 4.3% 2.8% - 3.3% Dividend rate 0.0 % 0.0 % Expected term (in years) 0.9 - 3.1 0.3 - 4.8
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	The weighted-average assumptions in the Black-Scholes option-pricing models used to determine the fair value of ESPP rights granted during the year ended January 31, 2024, 2023 and 2022 were as follows: Year Ended January 31, 2024 2023 2022 Expected volatility 62.3% - 70.8% 64.9% - 72.2% 61.8% - 73.5% Risk-free interest rate 4.5% - 5.4% 0.8% - 3.6% 0.1% - 0.3% Dividend rate 0.0 % 0.0 % 0.0 % Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.4 - 1.9
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	The 2021 EIP provides for the issuance of RSUs to employees and directors. A summary of activity of RSUs under the 2021 EIP at January 31, 2024 and changes during the periods then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 12,935,413 $ 15.02 RSU granted 26,348,986 $ 5.85 RSU vested (6,249,909) $ 13.53 RSU forfeited (4,618,363) $ 11.95 Outstanding as of January 31, 2024 28,416,127 $ 7.35 A summary of activity of PRSUs under the 2021 EIP at January 31, 2024 and changes during the periods then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 2,147,366 $ 10.83 PRSU granted 1,621,236 $ 2.84 PRSU forfeited (620,820) $ 10.47 Outstanding as of January 31, 2024 3,147,782 $ 6.79

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	The components of net loss before income taxes were as follows: Year Ended January 31, 2024 2023 2022 (in thousands) Domestic $ (457,788) $ (342,999) $ (131,916) Foreign 158 (4,276) (3,255) Net loss before income taxes $ (457,630) $ (347,275) $ (135,171)
Schedule of Components of Income Tax Expense (Benefit)	The components of the provision for (benefit from) income taxes were as follows: Year Ended January 31, 2024 2023 2022 (in thousands) Current Federal $ 218 $ — $ — State 17 44 17 Foreign 1,942 1,345 359 Total current $ 2,177 $ 1,389 $ 376 Deferred Federal $ — $ 1 $ (1,242) State — — (423) Foreign (2,198) (3,557) (1,641) Total deferred (2,198) (3,556) (3,306) Total benefit from income taxes $ (21) $ (2,167) $ (2,930)
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows: Year Ended January 31, 2024 2023 2022 Tax at federal statutory rate 21.0 % 21.0 % 21.0 % State tax rate, net — % — % — % Warrant and earnout revaluation — % — % 20.9 % Stock-based compensation (2.6 %) — % 8.0 % Intangible assets amortization — % — % 1.3 % Change in valuation allowance (19.5 %) (18.9 %) (45.5 %) Transaction cost — % — % (1.2 %) Research and development tax credits 0.6 % 0.8 % 2.8 % Section 162(m) executive compensation limitation — % (1.2) % (5.3) % Other 0.6 % (1.1) % 0.2 % Effective tax rate 0.1 % 0.6 % 2.2 %
Schedule of Deferred Tax Assets and Liabilities	The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2024 and 2023 were as follows: Year Ended January 31, 2024 2023 (in thousands) Deferred tax assets: Net operating losses $ 246,396 $ 216,642 Research & development credits 42,541 34,406 Deferred revenue 27,788 18,124 Accruals and reserves 47,279 18,837 Stock-based compensation 15,300 11,706 Operating lease liabilities 5,524 6,589 Capitalized research & development expense 69,070 39,761 Total deferred tax assets 453,898 346,065 Less: valuation allowance (439,447) (328,786) Deferred tax liabilities: Depreciation and amortization (557) (390) Operating lease right-of-use assets (3,886) (5,723) Acquired intangible assets (18,985) (22,058) Deferred commission (2,275) (2,095) Total deferred tax liabilities (25,703) (30,266) Net deferred tax assets (liabilities) $ (11,252) $ (12,987)
Schedule of Unrecognized Tax Benefits Roll Forward	The following table summarizes the activity related to unrecognized tax benefits as follows: Year Ended January 31, 2024 2023 2022 (in thousands) Unrecognized tax benefits - beginning $ 25,762 $ 19,238 $ 9,402 Gross changes - prior period tax position — 109 2,039 Gross changes - current period tax position 6,331 6,415 7,797 Unrecognized tax benefits — ending $ 32,093 $ 25,762 $ 19,238

Geographic Information (Tables)

Geographic Information (Tables)	12 Months Ended
	Jan. 31, 2024
Segment Reporting [Abstract]
Schedule of Revenue by Geographic Area	Revenue by geographic area based on the shipping address of the customers was as follows: Year Ended January 31, 2024 2023 2022 (in thousands) United States $ 380,067 $ 373,736 $ 205,186 Rest of World 126,572 94,358 35,820 Total revenue $ 506,639 $ 468,094 $ 241,006
Long-lived Assets by Geographic Areas	Long-lived assets by geographic area were as follows: January 31, 2024 2023 (in thousands) United States $ 65,468 $ 71,032 Netherlands 66,241 76,747 Rest of World 6,654 7,182 Total long-lived assets $ 138,363 $ 154,961

Basic and Diluted Net Loss pe_2

Basic and Diluted Net Loss per Share (Tables)	12 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Schedule of Loss Per Share Attributable to Common Stockholders, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended January 31, 2024, 2023, and 2022: Year Ended January 31, 2024 2023 2022 (in thousands, except share and per share data) Numerator: Net income (loss) $ (457,609) $ (345,108) $ (132,241) Adjust: Cumulative dividends on redeemable convertible preferred stock — — (4,292) Adjust: Deemed dividends attributable to vested option holders — — (51,855) Adjust: Deemed dividends attributable to common stock warrant holders — — (110,635) Net loss attributable to common stockholders - Basic $ (457,609) $ (345,108) $ (299,023) Less: Gain attributable to earnout shares issued — — (84,420) Less: Change in fair value of dilutive warrants — — (68,223) Net loss attributable to common stockholders - Diluted $ (457,609) $ (345,108) $ (451,666) Denominator: Weighted average common shares outstanding (1) 375,543,916 338,576,326 297,642,999 Less: Weighted-average unvested restricted shares and shares subject to repurchase (14,033) (87,659) (221,030) Weighted average shares outstanding - Basic 375,529,883 338,488,667 297,421,969 Add: Earnout Shares under the treasury stock method — — 3,701,427 Add: Public and Private Placement Warrants under the treasury stock method — — 1,366,870 Weighted average shares outstanding - Diluted 375,529,883 338,488,667 302,490,266 Net loss per share - Basic $ (1.22) $ (1.02) $ (1.01) Net loss per share - Diluted (2) $ (1.22) $ (1.02) $ (1.49) _______________ (1) For the fiscal year ended January 31, 2022, as a result of the Merger, the Company retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to the Closing Date by multiplying them by the Exchange Ratio of 0.9966 used to determine the number of shares of Common Stock into which they converted. The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis. (2) For the fiscal year ended January 31, 2022, redeemable convertible preferred stock and preferred stock warrants outstanding prior to the Merger Closing Date were excluded because including them would have had an antidilutive effect.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows: Year Ended January 31, 2024 2023 2022 2028 Convertible Notes (on an as-converted basis) 24,999,990 12,483,569 — Options to purchase common stock 11,396,756 17,600,524 22,200,869 Restricted stock units 28,416,127 12,935,413 4,033,418 Unvested early exercised common stock options 665 40,555 132,180 Common stock warrants 34,499,436 34,499,436 35,549,024 Employee stock purchase plan 9,348,659 1,835,659 894,348 Total potentially dilutive common share equivalents 108,661,633 79,395,156 62,809,839

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
	Jan. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost	The following table summarizes the January 2024 Reorganization charges by line item within the Company’s consolidated statements of operations for the year ended January 31, 2024: Severances and employment-related termination costs Facility and other contract terminations Total (in thousands) Cost of revenue $ 632 $ — $ 632 Research and development 7,540 — 7,540 Sales and marketing 500 — 500 General and administrative 1,274 2,708 3,982 Total $ 9,946 $ 2,708 $ 12,654 The following table summarizes the September 2023 Reorganization charges by line item within the Company’s statement of operations for the year ended January 31, 2024: Severances and employment-related termination costs Facility and other contract terminations Total (in thousands) Cost of revenue $ 996 $ — $ 996 Research and development 4,183 — 4,183 Sales and marketing 1,343 — 1,343 General and administrative 890 8,189 9,079 Total $ 7,412 $ 8,189 $ 15,601

Description of Business and B_2

Description of Business and Basis of Presentation (Details) - USD ($) $ / shares in Units, $ in Thousands					1 Months Ended	12 Months Ended
	Feb. 03, 2022	Oct. 06, 2021	Aug. 11, 2021	Feb. 26, 2021	Feb. 28, 2021	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Business Acquisition [Line Items]
Accumulated deficit						$ (1,614,372)	$ (1,156,763)
Proceeds from merger					$ 484,100
Cash, cash equivalents, and restricted cash and short-term investments						357,800
Transaction costs expensed						$ 0	$ 0	$ (7,031)
Value of shares in escrow		$ 15,900
Switchback
Business Acquisition [Line Items]
Proceeds from merger				$ 225,000
Net cash contributions from merger				511,600
Cash - Switchback's trust and cash				286,600
Repurchase of common stock				300
Transaction costs expensed				36,500
Transaction costs expensed				7,000
Switchback | Additional Paid-In Capital
Business Acquisition [Line Items]
Reduction to APIC				$ 29,500
ViriCiti Earnout liability | Level 3 | Contingent Consideration Liability
Business Acquisition [Line Items]
Transfer out of Level 3 upon achievement of earnings target for the earnout period			$ 7,100
ViriCiti
Business Acquisition [Line Items]
Cash consideration			$ 79,400
HTB
Business Acquisition [Line Items]
Cash consideration		132,900
Total purchase consideration		235,000
Common Stock consideration		$ 102,100
Equity transferred (in shares)		5,695,176
Equity transferred (in USD per share)		$ 17.92
Payments for working capital adjustment	$ 2,800
Shares held in escrow (in shares)		885,692
Indemnity claim period		18 months

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Customer Concentration Risk - Largest Customer	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage	10%	10%
Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	10%	10%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Segment Reporting (Details)	12 Months Ended
	Jan. 31, 2024 segment
Accounting Policies [Abstract]
Number of operating segments	1

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Accounting Policies [Abstract]
Cash and cash equivalents	$ 327,410	$ 264,162	$ 315,235
Restricted cash	30,400	30,400	400
Total cash, cash equivalents, and restricted cash	$ 357,810	$ 294,562	$ 315,635	$ 145,891

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Short-Term Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2024
Debt Securities, Available-for-Sale [Line Items]
Short-term investments	$ 104,966	$ 0
Accrued interest receivable	$ 500
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]	Short-term investments
U.S. Treasury securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 105,415
Gross Unrealized Gains	0
Gross Unrealized Losses	(449)
Short-term investments	$ 104,966

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Short-Term Investments Narrative (Details) $ in Thousands	12 Months Ended
	Jan. 31, 2023 USD ($)
U.S. Treasury securities
Debt Securities, Available-for-Sale [Line Items]
Gross unrealized losses	$ 449

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Allowance for Credit Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ 10,000	$ 5,584	$ 2,000
Change in Provision	6,026	6,353	3,835
Write-offs	(2,026)	(1,937)	(251)
Ending Balance	$ 14,000	$ 10,000	$ 5,584

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)	Jan. 31, 2024
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Computers and software | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Computers and software | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Tooling | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Tooling | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Owned and operated systems | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Owned and operated systems | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	7 years

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Accounting Policies [Abstract]
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued and other current liabilities	Accrued and other current liabilities
Impairment of operating lease right-of-use assets	$ 2.7

Summary of Significant Accou_12

Summary of Significant Accounting Policies - Schedule of Fair Value (Details) - Fair Value, Recurring $ in Thousands	Jan. 31, 2023 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	$ 238,945
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	133,979
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	104,966
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	133,979
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	133,979
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	0
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	104,966
U.S. Treasury securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	0
U.S. Treasury securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	104,966
U.S. Treasury securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets, fair value	$ 0

Summary of Significant Accou_13

Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) - USD ($)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounting Policies [Abstract]
Impairment of long-lived assets	$ 0	$ 0	$ 0

Summary of Significant Accou_14

Summary of Significant Accounting Policies - Intangible Assets (Details)	12 Months Ended
	Jan. 31, 2024
Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets, useful life (in years)	6 years
Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets, useful life (in years)	10 years

Summary of Significant Accou_15

Summary of Significant Accounting Policies - Goodwill (Details) - USD ($)	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounting Policies [Abstract]
Goodwill	$ 213,750,000	$ 213,716,000	$ 218,484,000
Goodwill impairment	$ 0

Summary of Significant Accou_16

Summary of Significant Accounting Policies - Revenue (Details)	12 Months Ended
	Jan. 31, 2024
Minimum
Disaggregation of Revenue [Line Items]
Subscription term	1 year
Contract terms	30 days
Maximum
Disaggregation of Revenue [Line Items]
Subscription term	5 years
Contract terms	90 days

Summary of Significant Accou_17

Summary of Significant Accounting Policies - Remaining Performance Obligations (Details) $ in Millions	12 Months Ended
	Jan. 31, 2024 USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 255.8
Minimum
Deferred Revenue Arrangement [Line Items]
Subscription term	1 year
Maximum
Deferred Revenue Arrangement [Line Items]
Subscription term	5 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue expected to be recognized from remaining performance obligations (as percent)	42%
Revenue expected to be recognized from remaining performance obligations (in months)	12 months

Summary of Significant Accou_18

Summary of Significant Accounting Policies - Deferred Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounting Policies [Abstract]
Contract with customer liability	$ 231,439	$ 198,610
Contract with customer liability, revenue recognized	$ 88,777	$ 77,142	$ 40,934

Summary of Significant Accou_19

Summary of Significant Accounting Policies - Cost to Obtain Customer Contract (Details)	Jan. 31, 2024
Accounting Policies [Abstract]
Capitalized contract cost, amortization period (in years)	5 years

Summary of Significant Accou_20

Summary of Significant Accounting Policies - Rollforward of Deferred Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 8,142	$ 7,129
Capitalization of deferred contract acquisition costs	3,711	3,374
Amortization of deferred contract acquisition costs	(2,859)	(2,361)	$ (1,786)
Ending balance	$ 8,994	$ 8,142	$ 7,129

Summary of Significant Accou_21

Summary of Significant Accounting Policies - Schedule of Deferred Costs (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounting Policies [Abstract]
Deferred contract acquisition costs, current	$ 3,013	$ 2,598
Deferred contract acquisition costs, noncurrent	5,981	5,544
Total deferred contract acquisition costs	$ 8,994	$ 8,142	$ 7,129

Summary of Significant Accou_22

Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounting Policies [Abstract]
Advertising Expense	$ 0	$ 0	$ 0

Summary of Significant Accou_23

Summary of Significant Accounting Policies - Warranty (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Accounting Policies [Abstract]
Warranty expense	$ 16.7	$ 5.4	$ 3.8
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Subscription terms (in years)	1 year
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Subscription terms (in years)	5 years

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Beginning balance	$ 213,716	$ 218,484
Foreign exchange fluctuations	34	(4,768)
Ending balance	$ 213,750	$ 213,716

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Business Acquisition [Line Items]
Cost	$ 109,113	$ 109,093
Accumulated amortization	(28,558)	(16,420)
Total amortization expense	80,555	92,673
Customer relationships
Business Acquisition [Line Items]
Cost	90,755	90,738
Accumulated amortization	(21,301)	(12,223)
Total amortization expense	$ 69,454	$ 78,515
Useful life (in years)	10 years	10 years
Developed technology
Business Acquisition [Line Items]
Cost	$ 18,358	$ 18,355
Accumulated amortization	(7,257)	(4,197)
Total amortization expense	$ 11,101	$ 14,158
Useful life (in years)	6 years	6 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of acquired intangible assets and goodwill	$ 0	$ 0

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization Expense	$ 12,140	$ 11,646	$ 4,617

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets - Maturity of Amortization Expense (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 12,134
2026	12,134
2027	12,134
2028	10,996
2029	9,075
Thereafter	24,082
Total amortization expense	$ 80,555	$ 92,673

Balance Sheet Components - Inve

Balance Sheet Components - Inventories (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 5,322	$ 11,509
Finished goods	193,258	57,221
Total Inventories	198,580	68,730
Inventory impairment	$ 70,000	$ 0	$ 0

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expense and Other Current Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expense	$ 43,389	$ 48,464
Other Assets, Current	18,855	22,556
Prepaid expenses and other current assets	$ 62,244	$ 71,020

Balance Sheet Components - Prop

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment	$ 101,905	$ 83,600
Less: Accumulated depreciation	(59,459)	(43,554)
Total Property and Equipment, Net	42,446	40,046
Depreciation expense	16,345	13,404	$ 11,840
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment	1,718	1,244
Computers and software
Property, Plant and Equipment [Line Items]
Property and equipment	8,520	7,164
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property and equipment	35,954	25,144
Tooling
Property, Plant and Equipment [Line Items]
Property and equipment	15,852	13,782
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment	9,828	9,357
Owned and operated systems
Property, Plant and Equipment [Line Items]
Property and equipment	27,723	24,119
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment	$ 2,310	$ 2,790

Balance Sheet Components - Accr

Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 51,399	$ 46,105
Reserve for losses on non-cancellable purchase commitments	30,054	7,287
Refundable customer deposits	16,588	14,551
Payroll and related expenses	16,018	21,495
Taxes payable	14,294	14,232
Other current liabilities	30,751	29,813
Total Accrued and Other Current Liabilities	$ 159,104	$ 133,483

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Lease cost	$ 6	$ 6.6	$ 6.1
Minimum
Lessee, Lease, Description [Line Items]
Lease renewal term (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lease renewal term (in years)	5 years

Leases - Schedule of Lease Asse

Leases - Schedule of Lease Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Leases [Abstract]
Operating leases	$ 15,362	$ 22,242
Operating lease liabilities, current	4,485	3,753
Operating lease liabilities	17,350	21,841
Total operating lease liabilities	$ 21,835	$ 25,594

Leases - Schedule of Lease Matu

Leases - Schedule of Lease Maturity (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Leases [Abstract]
2025	$ 6,495
2026	5,198
2027	4,703
2028	4,100
2029	3,921
Thereafter	2,301
Total undiscounted operating lease payments	26,718
Less: imputed interest	(4,883)
Total operating lease liabilities	$ 21,835	$ 25,594

Leases - Other Supplemental Inf

Leases - Other Supplemental Information (Details)	Jan. 31, 2024	Jan. 31, 2023
Leases [Abstract]
Weighted-average remaining operating lease term (years)	4 years 10 months 24 days	5 years 8 months 12 days
Weighted-average operating lease discount rate	7.40%	7.30%

Leases - Cash Flow Information

Leases - Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Leases [Abstract]
Cash paid for amounts in the measurement of operating lease liabilities	$ 6,760	$ 6,927	$ 5,164

Debt - Narrative (Details)

Debt - Narrative (Details)			1 Months Ended			12 Months Ended
	Oct. 24, 2023 $ / shares	Jul. 27, 2023 USD ($)	Apr. 30, 2022 USD ($) day $ / shares	Mar. 31, 2021 USD ($)	Jul. 31, 2018 USD ($)	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)	Jan. 31, 2022 USD ($)
Line of Credit
Debt Instrument [Line Items]
Extinguishment of debt				$ 35,000,000
Interest and prepayment fees				$ 1,200,000
Line of Credit | Medium-term Notes | 2018 Loan
Debt Instrument [Line Items]
Maximum borrowing capacity					$ 45,000,000
Borrowings						$ 35,000,000
Issuance costs						1,100,000
Net proceeds from line of credit					$ 33,900,000
Debt maturity (in years)					5 years
Interest expense						0	$ 0	$ 1,500,000
Line of Credit | Medium-term Notes | 2018 Loan | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate					6.55%
Line of Credit | Revolving Credit Facility | 2027 Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 150,000,000
Interest rate (as a percent)		1.75%
Commitment fee		0.40%
Borrowing capacity						150,000,000
Line of Credit | Revolving Credit Facility | 2027 Revolving Credit Facility | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate		2.75%
Participation fee		2.25%
Borrowings outstanding						0
Line of Credit | Revolving Credit Facility | 2027 Revolving Credit Facility | Euro Interbank Offered Rate (EURIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate		2.75%
Line of Credit | Revolving Credit Facility | 2027 Revolving Credit Facility | Daily Simple Risk-Free Rate
Debt Instrument [Line Items]
Basis spread on variable rate		2.75%
Line of Credit | Letter of Credit | 2027 Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 100,000,000
Minimum total liquidity		150%
Line of Credit | Letter of Credit | 2027 Revolving Credit Facility | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Borrowings outstanding						0
Convertible Debt | 2028 Convertible Notes
Debt Instrument [Line Items]
Borrowings						300,000,000	300,000,000
Debt instrument, face amount			$ 300,000,000
Carrying amount			$ 294,000,000			$ 283,704,000	294,936,000
Conversion price (in dollars per share) | $ / shares	$ 12		$ 24.03
Ratio of repurchase price to principal amount						100%
Ratio of control price to principal amount						125%
Interest rate, effective percentage						8.59%
Long-term debt, fair value						$ 211,000,000	$ 233,000,000
Conversion ratio	0.083333		0.0416119
Convertible Debt | 2028 Convertible Notes | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Threshold trading days | day			20
Threshold consecutive trading days | day			30
Threshold percentage of stock price trigger (as a percent)			130%
Convertible Debt | 2028 Convertible Notes | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Threshold trading days | day			5
Threshold consecutive trading days | day			10
Threshold percentage of stock price trigger (as a percent)			98%
Convertible Debt | 2028 Convertible Notes | Cash Interest
Debt Instrument [Line Items]
Interest rate (as a percent)	7%		3.50%
Convertible Debt | 2028 Convertible Notes | Paid In Kind Interest
Debt Instrument [Line Items]
Interest rate (as a percent)	8.50%		5%
Secured Debt | 2028 Convertible Notes
Debt Instrument [Line Items]
Maximum covenant threshold						$ 750,000,000
Trustee percentage (as a percent)						25%
Declare percentage						100%

Debt - Schedule of Convertible

Debt - Schedule of Convertible Debt (Details) - 2028 Convertible Notes - Convertible Debt - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2022
Debt Instrument [Line Items]
Gross Amount	$ 300,000	$ 300,000
Debt discount and issuance costs	(16,296)	(5,064)
Carrying amount	283,704	294,936	$ 294,000
Estimated fair value (Level 2 Inputs)	$ 211,000	$ 233,000

Debt - Schedule of Interest Exp

Debt - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
2028 Convertible Notes
Debt Instrument [Line Items]
Contractual interest expense	$ 13,548	$ 8,429
Amortization of debt discount and issuance costs	1,993	965
Total interest expense	15,541	$ 9,394
2027 Revolving Credit Facility
Debt Instrument [Line Items]
Amortization of debt discount and issuance costs	417
Commitment fees	315
Total interest expense	$ 732

Commitment and Contingencies -

Commitment and Contingencies - Narrative (Details) - USD ($) $ in Millions	Jan. 31, 2024	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 30.4	$ 30.4

Common Stock - Narrative (Detai

Common Stock - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Jul. 31, 2022 USD ($)	Jan. 31, 2024 USD ($) vote $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) shares	Jul. 01, 2022 shares	Jan. 31, 2021 shares
Class of Stock [Line Items]
Issuance of common stock upon the reverse recapitalization, net of issuance costs | $				$ 200,466
Common stock, shares outstanding (in shares)		421,116,720	348,330,481
Common stock, par value (USD per share) | $ / shares		$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)		1,000,000,000	1,000,000,000
Common Stock, shares issued (in shares)		421,116,720	348,330,481
Number of votes | vote		1
At-The-Market Offering
Class of Stock [Line Items]
Common stock, shares authorized (in shares)					1,000,000,000
Number of shares sold (in shares)		59,299,481	4,657,806
Maximum consideration receivable | $	$ 500,000
Consideration received on sold shares | $		$ 287,200	$ 49,500
Issuance costs | $		$ 1,200	$ 500
Common Stock
Class of Stock [Line Items]
Merger and PIPE financing shares (in shares)				60,746,989
Issuance of common stock upon the reverse recapitalization, net of issuance costs | $				$ 6
Shares outstanding (in shares)		421,116,720	348,330,481	334,760,615		22,961,032
Additional Paid-In Capital
Class of Stock [Line Items]
Issuance of common stock upon the reverse recapitalization, net of issuance costs | $				$ 200,460

Common Stock - Reserved for Fut

Common Stock - Reserved for Future Issuance (Details)	Jan. 31, 2024 shares
2021 Stock Option Plan
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	34,331,567
Employee stock purchase plan
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	13,139,772

Stock Warrants - Narrative (Det

Stock Warrants - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Jul. 06, 2021	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022	Feb. 21, 2022	Jun. 04, 2021
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		34,499,436	34,499,436
Warrants exercised (in shares)		0
Proceeds from the exercise of public warrants		$ 0	$ 6,884	$ 118,864
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Change in fair value of warrant liabilities	Change in fair value of warrant liabilities	Change in fair value of warrant liabilities
Common Stock
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		34,499,436
Common Stock | Legacy Chargepoint
Class of Warrant or Right [Line Items]
Issuance of common stock upon exercise of warrants (in shares)			1,037,808
Legacy Common And Preferred Stock Warrants Classified As Equity
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		38,761,031
Legacy Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		34,499,436	34,499,436
Warrants exercised (in shares)		0
Legacy Warrants | Common Stock | Legacy Chargepoint
Class of Warrant or Right [Line Items]
Warrants exercised (in shares)		0	1,039,153
Legacy Common Stock Warrants
Class of Warrant or Right [Line Items]
Proceeds from the exercise of public warrants			$ 6,900
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		0	0
Warrants exercised (in shares)		0
Proceeds from the exercise of public warrants			$ 117,600
Fair value adjustment of warrants			63,700
Value per common share					$ 0.355
Public Warrants
Class of Warrant or Right [Line Items]
Fair value adjustment of warrants		$ 0	$ 0	$ 15,900
Number of warrants called for redemption (in shares)						244,481
Class of warrants redeemed Or called during period (in shares)	244,481
Class of warrants redemption price per warrant (in dollar per share)	0.01

Stock Warrants - Schedule of Wa

Stock Warrants - Schedule of Warrants Outstanding (Details) - $ / shares	Jan. 31, 2024	Jan. 31, 2023
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	34,499,436	34,499,436
Common Stock Warrant, Expires in 2030
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	20,922,215
Stock price of warrants (in dollars per share)	$ 6.03
Common Stock Warrant, Expires in 2028 Through 2029
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	13,577,221
Stock price of warrants (in dollars per share)	$ 9.04

Stock Warrants - Fair Value Inp

Stock Warrants - Fair Value Inputs of Warrants and Contingent Earnout Liability (Details) - Private Placement Warrants	Jan. 31, 2022 $ / shares	Feb. 26, 2021 $ / shares
Current stock price
Class of Warrant or Right [Line Items]
Warrants, measurement input	13.85	30.83
Exercise price
Class of Warrant or Right [Line Items]
Warrants, measurement input	11.50	11.50
Expected term (years)
Class of Warrant or Right [Line Items]
Warrants, measurement input	4.1	5
Expected volatility
Class of Warrant or Right [Line Items]
Warrants, measurement input	0.705	0.735
Risk-free interest rate
Class of Warrant or Right [Line Items]
Warrants, measurement input	0.010	0.008
Dividend rate
Class of Warrant or Right [Line Items]
Warrants, measurement input	0	0

Stock Warrants - Warrant Activi

Stock Warrants - Warrant Activity (Details)	12 Months Ended
	Jan. 31, 2024 shares
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)	34,499,436
Warrants exercised (in shares)	0
Outstanding at end of period (in shares)	34,499,436
Legacy Warrants
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)	34,499,436
Warrants exercised (in shares)	0
Outstanding at end of period (in shares)	34,499,436
Private Placement Warrants
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)	0
Warrants exercised (in shares)	0
Outstanding at end of period (in shares)	0

Equity Plans and Stock-based _3

Equity Plans and Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 117,337	$ 93,350	$ 67,331
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	6,154	4,351	3,782
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	50,935	37,967	25,461
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	22,934	17,393	9,154
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 37,314	$ 33,639	$ 28,934

Equity Plans and Stock-based _4

Equity Plans and Stock-based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Feb. 25, 2021	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Unrecognized stock-based compensation cost not yet recognized		$ 175.8
Period for recognition (in years)		2 years 7 months 6 days
2021 Equity Incentive Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Possible increase in percent of outstanding shares (as a percent)	1%
Number of additional shares allowable under the plan (in shares)	5,400,000
Percent of outstanding shares (as a percent)	5%
2021 Stock Option Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Total shares of common stock reserved (in shares)		34,331,567
Number of stock options granted (in shares)		0
2017 Stock Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Total shares of common stock reserved (in shares)			10,369,118
2007 Stock Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Total shares of common stock reserved (in shares)			1,027,638
Employee stock purchase plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Eligible compensation per employee (as a percent)	15%
Offering period (in months)	24 months
Purchase period (in months)	6 months
Purchase price of common stock, percent of fair value	85%
Maximum number of shares to be purchased per employee (in shares)	10,000
Total shares of common stock reserved (in shares)		13,139,772
Shares purchased (in shares)		1,273,933	607,384
Price per share (USD per share)		$ 6.54	$ 14.73
Proceeds from shares purchased		$ 8.3	$ 8.9
Restricted stock units
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Fair value of awards vested		84.5	58.4	$ 37.8
Options to purchase common stock | 2017 Stock Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Grant date fair value		$ 46.3	$ 2	$ 3.4
Performance Restricted Stock Units | 2021 Equity Incentive Plan | Minimum
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Vesting period (in years)		4 years
Performance Restricted Stock Units | 2021 Equity Incentive Plan | Maximum
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Vesting period (in years)		5 years

Equity Plans and Stock-Based _5

Equity Plans and Stock-Based Compensation - Fair Value Assumptions (Details) - Employee stock purchase plan	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, minimum	62.30%	64.90%	61.80%
Expected volatility, maximum	70.80%	72.20%	73.50%
Risk-free interest rate, minimum	4.50%	0.80%	0.10%
Risk-free interest rate, maximum	5.40%	3.60%	0.30%
Dividend rate	0%	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months	4 months 24 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years	2 years	1 year 10 months 24 days

Equity Plans and Stock-Based _6

Equity Plans and Stock-Based Compensation - Restricted Stock Units Activity (Details)	12 Months Ended
	Jan. 31, 2024 $ / shares shares
Restricted stock units
Number of Shares
Outstanding, beginning balance (in shares) | shares	12,935,413
Granted (in shares) | shares	26,348,986
Vested (in shares) | shares	(6,249,909)
Forfeited (in shares) | shares	(4,618,363)
Outstanding, ending balance (in shares) | shares	28,416,127
Weighted Average Grant Date Fair Value per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 15.02
Granted (in dollars per share) | $ / shares	5.85
Vested (in dollars per share) | $ / shares	13.53
Forfeited (in dollars per share) | $ / shares	11.95
Outstanding, ending balance (in dollars per share) | $ / shares	$ 7.35
Performance Restricted Stock Units
Number of Shares
Outstanding, beginning balance (in shares) | shares	2,147,366
Granted (in shares) | shares	1,621,236
Forfeited (in shares) | shares	(620,820)
Outstanding, ending balance (in shares) | shares	3,147,782
Weighted Average Grant Date Fair Value per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 10.83
Granted (in dollars per share) | $ / shares	2.84
Forfeited (in dollars per share) | $ / shares	10.47
Outstanding, ending balance (in dollars per share) | $ / shares	$ 6.79

Equity Plans and Stock-based _7

Equity Plans and Stock-based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Number of Stock Option Awards
Outstanding as of beginning of period (in shares)	17,600,524
Options exercised (in shares)	(5,976,138)
Cancelled (in shares)	(227,630)
Outstanding as end of period (in shares)	11,396,756	17,600,524
Options vested and expected to vest at end of period (in shares)	11,396,739
Exercisable at end of period (in shares)	11,301,564
Weighted Average Exercise Price
Outstanding as of beginning of period (USD per share)	$ 0.70
Options exercised (USD per share)	0.63
Cancelled (USD per share)	0.77
Outstanding as of end of period (USD per share)	0.74	$ 0.70
Options vested and expected to vest as of end of period (USD per share)	0.74
Exercisable as of end of period (USD per share)	$ 0.73
Weighted Average Remaining Contractual term (in years)
Outstanding (in years)	4 years 9 months 18 days	5 years 7 months 6 days
Options vested and expected to vest (in years)	4 years 9 months 18 days
Exercisable (in years)	4 years 9 months 18 days
Aggregate Intrinsic Value (in thousands)
Outstanding	$ 13,276	$ 201,352
Options vested and expected to vest	13,276
Exercisable	$ 13,167

Equity Plans and Stock-Based _8

Equity Plans and Stock-Based Compensation - Valuation Assumptions (Details) - Performance Restricted Stock Units	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, minimum	68.40%	72.10%
Expected volatility, maximum	82.40%	74%
Risk-free interest rate, minimum	4%	2.80%
Risk-free interest rate, maximum	4.30%	3.30%
Dividend rate	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	10 months 24 days	3 months 18 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	3 years 1 month 6 days	4 years 9 months 18 days

Income Taxes - Provision for In

Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Loss before income taxes
Domestic	$ (457,788)	$ (342,999)	$ (131,916)
Foreign	158	(4,276)	(3,255)
Net loss before income taxes	$ (457,630)	$ (347,275)	$ (135,171)

Income Taxes - Components of th

Income Taxes - Components of the Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Current
Federal	$ 218	$ 0	$ 0
State	17	44	17
Foreign	1,942	1,345	359
Total current	2,177	1,389	376
Deferred
Federal	0	1	(1,242)
State	0	0	(423)
Foreign	(2,198)	(3,557)	(1,641)
Total deferred	(2,198)	(3,556)	(3,306)
Total benefit from income taxes	$ (21)	$ (2,167)	$ (2,930)

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Effective Income Tax Rate (Details)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Tax at federal statutory rate	21%	21%	21%
State tax rate, net	0%	0%	0%
Warrant and earnout revaluation	0%	0%	20.90%
Stock-based compensation	(2.60%)	0%	8%
Intangible assets amortization	0%	0%	1.30%
Change in valuation allowance	(19.50%)	(18.90%)	(45.50%)
Transaction cost	0%	0%	(1.20%)
Research and development tax credits	0.60%	0.80%	2.80%
Section 162(m) executive compensation limitation	0%	(1.20%)	(5.30%)
Other	0.60%
Other		(1.10%)	0.20%
Effective tax rate	0.10%	0.60%	2.20%

Income Taxes - Components of _2

Income Taxes - Components of the Company's Deferred Income Tax Assets (Liabilities) (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Deferred tax assets:
Net operating losses	$ 246,396	$ 216,642
Research & development credits	42,541	34,406
Deferred revenue	27,788	18,124
Accruals and reserves	47,279	18,837
Stock-based compensation	15,300	11,706
Operating lease liabilities	5,524	6,589
Capitalized research & development expense	69,070	39,761
Total deferred tax assets	453,898	346,065
Less: valuation allowance	(439,447)	(328,786)
Deferred tax liabilities:
Depreciation and amortization	(557)	(390)
Operating lease right-of-use assets	(3,886)	(5,723)
Acquired intangible assets	(18,985)	(22,058)
Deferred commission	(2,275)	(2,095)
Total deferred tax liabilities	(25,703)	(30,266)
Net deferred tax liabilities	$ (11,252)	$ (12,987)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
Increase in valuation allowance	$ 110,700	$ 88,200	$ 89,600
Operating Loss Carryforwards [Line Items]
Increase in valuation allowance	110,700	88,200	89,600
Indefinite domestic operating loss carryforward	719,600
Unrecognized tax benefits	32,093	25,762	$ 19,238	$ 9,402
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	908,400	408,100
Research tax credit carryforward	41,100	$ 37,700
Operating loss carryforward subject to expiration	17,100
Other States
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	375,700
Operating loss carryforward subject to expiration	4,700
California
Operating Loss Carryforwards [Line Items]
Operating loss carryforward subject to expiration	$ 17,900

Income Taxes - Reconciliation_2

Income Taxes - Reconciliation of the Beginning and Ending Amount of Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits - beginning	$ 25,762	$ 19,238	$ 9,402
Gross changes - prior period tax position	0	109
Gross changes - prior period tax position			2,039
Gross changes - current period tax position	6,331	6,415	7,797
Unrecognized tax benefits — ending	$ 32,093	$ 25,762	$ 19,238

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 506,639	$ 468,094	$ 241,006
United States
Disaggregation of Revenue [Line Items]
Total revenue	380,067	373,736	205,186
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 126,572	$ 94,358	$ 35,820

Geographic Information - Long-L

Geographic Information - Long-Lived Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Long Lived Assets Held-for-sale [Line Items]
Total long-lived assets	$ 138,363	$ 154,961
United States
Long Lived Assets Held-for-sale [Line Items]
Total long-lived assets	65,468	71,032
Netherlands
Long Lived Assets Held-for-sale [Line Items]
Total long-lived assets	66,241	76,747
Rest of World
Long Lived Assets Held-for-sale [Line Items]
Total long-lived assets	$ 6,654	$ 7,182

Basic and Diluted Net Loss pe_3

Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Loss per Share (Details)	12 Months Ended
	Jan. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares
Numerator:
Net income (loss)	$ (457,609,000)	$ (345,108,000)	$ (132,241,000)
Cumulative undeclared dividends on redeemable convertible preferred stock	0	0	(4,292,000)
Deemed dividends attributable to vested option holders	0	0	(51,855,000)
Deemed dividends attributable to common stock warrant holders	0	0	(110,635,000)
Net loss attributable to common stockholders - Basic	(457,609,000)	(345,108,000)	(299,023,000)
Gain attributable to earnout shares issued	0	0	(84,420,000)
Change in fair value of dilutive warrants	0	0	(68,223,000)
Net loss attributable to common stockholders - Diluted	$ (457,609,000)	$ (345,108,000)	$ (451,666,000)
Denominator:
Weighted average common shares outstanding (in shares) | shares	375,543,916	338,576,326	297,642,999
Less: Weighted-average unvested restricted shares and shares subject to repurchase (in shares) | shares	(14,033)	(87,659)	(221,030)
Weighted average shares outstanding - Basic (in shares) | shares	375,529,883	338,488,667	297,421,969
Add: Earnout Shares under the treasury stock method (in shares) | shares	0	0	3,701,427
Add: Public and Private Placement Warrants under the treasury stock method (in shares) | shares	0	0	1,366,870
Weighted average shares outstanding - Diluted (in shares) | shares	375,529,883	338,488,667	302,490,266
Net loss per share - Basic (USD per share) | $ / shares	$ (1.22)	$ (1.02)	$ (1.01)
Net loss per share - Diluted (USD per share) | $ / shares	$ (1.22)	$ (1.02)	$ (1.49)
Recapitalization exchange ratio		0.9966

Basic and Diluted Net Loss pe_4

Basic and Diluted Net Loss per Share - Antidilutive Securities (Details) - shares	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	108,661,633	79,395,156	62,809,839
2028 Convertible Notes (on an as-converted basis)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	24,999,990	12,483,569	0
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	11,396,756	17,600,524	22,200,869
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	28,416,127	12,935,413	4,033,418
Unvested early exercised common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	665	40,555	132,180
Common stock warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	34,499,436	34,499,436	35,549,024
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents (in shares)	9,348,659	1,835,659	894,348

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) $ in Thousands	1 Months Ended	12 Months Ended
	Sep. 30, 2023 employee	Jan. 31, 2024 USD ($) employee
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 15,600
January 2024 Reorganization
Restructuring Cost and Reserve [Line Items]
Eliminated positions | employee		223
Percent of positions eliminated		12%
Severances and employment-related termination costs		$ 9,946
Facility and other contract terminations		2,708
Restructuring related liabilities		10,600
January 2024 Reorganization | Severance and employment-related exit cost
Restructuring Cost and Reserve [Line Items]
Restructuring related liabilities		10,200
January 2024 Reorganization | Facility exit cost
Restructuring Cost and Reserve [Line Items]
Restructuring related liabilities		400
September 2023 Reorganization
Restructuring Cost and Reserve [Line Items]
Eliminated positions | employee	168
Percent of positions eliminated	10%
Severances and employment-related termination costs		7,412
Facility and other contract terminations		8,189
Restructuring related liabilities		500
September 2023 Reorganization | Severance and employment-related exit cost
Restructuring Cost and Reserve [Line Items]
Restructuring related liabilities		300
September 2023 Reorganization | Facility exit cost
Restructuring Cost and Reserve [Line Items]
Restructuring related liabilities		$ 200

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Charges (Details) $ in Thousands	12 Months Ended
	Jan. 31, 2024 USD ($)
January 2024 Reorganization
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	$ 9,946
Facility and other contract terminations	2,708
Total	12,654
January 2024 Reorganization | Cost of revenue
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	632
Facility and other contract terminations	0
Total	632
January 2024 Reorganization | Research and development
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	7,540
Facility and other contract terminations	0
Total	7,540
January 2024 Reorganization | Sales and marketing
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	500
Facility and other contract terminations	0
Total	500
January 2024 Reorganization | General and administrative
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	1,274
Facility and other contract terminations	2,708
Total	3,982
September 2023 Reorganization
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	7,412
Facility and other contract terminations	8,189
Total	15,601
September 2023 Reorganization | Cost of revenue
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	996
Facility and other contract terminations	0
Total	996
September 2023 Reorganization | Research and development
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	4,183
Facility and other contract terminations	0
Total	4,183
September 2023 Reorganization | Sales and marketing
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	1,343
Facility and other contract terminations	0
Total	1,343
September 2023 Reorganization | General and administrative
Restructuring Cost and Reserve [Line Items]
Severances and employment-related termination costs	890
Facility and other contract terminations	8,189
Total	$ 9,079